| Main | News | Articles | Papers| About |

COVID-19 Scientific Papers
updated September 5, 2021 13:00 EDT

Caveat 1: There are thousands of papers being published and this is not in any way a representative sample.
Caveat 2: Research is happening at a very rapid pace, so keep in mind that something published just a few months or weeks ago may have already been superseded.

Earlier

  • 03/25/2008 Modeling targeted layered containment of an influenza pandemic in the United States | PNAS
  • 05/01/2007 Public health interventions and epidemic intensity during the 1918 influenza pandemic | PNAS
  • 09/02/2014 Quantification of Shared Air: A Social and Environmental Determinant of Airborne Disease Transmission
  • 03/02/2016 Pre-fusion structure of a human coronavirus spike protein | Nature
  • 07/11/2017 Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen | PNAS
  • 04/04/2018 Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin - PubMed

    January 2020

  • 01/27 Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China - Wang - 2020 - Journal of Medical Virology - Wiley Online Library
  • 01/30 Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany | NEJM

    February 2020

  • 02/09 Far-UVC light: A new tool to control the spread of airborne-mediated microbial diseases | Scientific Reports

    March 2020

  • 03/03 Fractal kinetics of COVID-19 pandemic | medRxiv
  • 03/09 Temperature and Latitude Analysis to Predict Potential Spread and Seasonality for COVID-19 :: SSRN
  • 03/16 Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand - Imperial College London [PDF]
  • 03/17 The proximal origin of SARS-CoV-2 | Nature Medicine
  • 03/17 Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 | NEJM
  • 03/27 Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma | JAMA | JAMA Network

    April 2020

  • 04/03 Respiratory virus shedding in exhaled breath and efficacy of face masks | Nature Medicine
  • 04/06 Quantifying the effect of quarantine control in Covid-19 infectious spread using machine learning | medRxiv
  • 04/07 Indoor transmission of SARS-CoV-2 | medRxiv
  • 04/07 Early Release - High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 - Volume 26, Number 7—July 2020 - Emerging Infectious Diseases journal - CDC
  • 04/10 Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China | Global Health | JAMA | JAMA Network
  • 04/10 Early Release - Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020 - Volume 26, Number 7—July 2020 - Emerging Infectious Diseases journal - CDC
  • 04/11 OSF | The Small World Network of College Classes: Implications for Epidemic Spread on a University Campus | Cornell
  • 04/12 Face Masks Against COVID-19: An Evidence Review[v1] | Preprints
  • 04/13 Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period | Science
  • 04/13 Universal Screening for SARS-CoV-2 in Women Admitted for Delivery | NEJM
  • 04/15 COVID-19: Hydroxychloroquine & Hypoxic Pneumonia / Timing of Viral Shedding & Transmission / Coinfection with Other Respiratory Pathogens
  • 04/15 Fast spread of COVID-19 in Europe and the US and its implications: even modest public health goals require comprehensive intervention | medRxiv
  • 04/18 Relative disease burdens of COVID-19 and seasonal influenza in New York City, February 1 - April 18, 2020. | medRxiv
  • 04/20 Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor | Nature
  • 04/22 National Covid-19 Testing Action Plan - Rockefeller Foundation [PDF]
  • 04/23 Modeling infectious disease dynamics | Science
  • 04/23 Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19 | medRxiv
  • 04/23 SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes | Nature Medicine
  • 04/24 Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial | Infectious Diseases | JAMA Network Open | JAM
  • 04/24 Aerosol Filtration Efficiency of Common Fabrics Used in Respiratory Cloth Masks | ACS Nano
  • 04/24 Early Release - Asymptomatic SARS-CoV-2 Infection in Household Contacts of a Healthcare Provider, Wuhan, China - Volume 26, Number 8—August 2020 - Emerging Infectious Diseases journal - CDC
  • 04/30 A rapid systematic review of the efficacy of face masks and respirators against coronaviruses and other respiratory transmissible viruses for the community, healthcare workers and sick patients

    May 2020

  • 05/05 Rapid development of an inactivated vaccine candidate for SARS-CoV-2 | Science
  • 05/07 Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial | medRxiv
  • 05/08 Harnessing multiple models for outbreak management | Science discussed here: 05/07 Which COVID-19 models should we use to make policy decisions?
  • 05/08 Impact of climate and public health interventions on the COVID-19 pandemic: a prospective cohort study | CMAJ
  • 05/11 COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions | Infectious Diseases | JAMA | JAMA Network
  • 05/12 The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission | PNAS
  • 05/12 Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study - The Lancet
  • 05/13 An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study - The Lancet
  • 05/13 An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study - The Lancet discussed here: 05/13 Kawasaki-like disease: emerging complication during the COVID-19 pandemic - The Lancet
  • 05/14 Assessment of Deaths From COVID-19 and From Seasonal Influenza | Geriatrics | JAMA Internal Medicine | JAMA Network
  • 05/14 Strong Social Distancing Measures In The United States Reduced The COVID-19 Growth Rate | Health Affairs
  • 05/15 Early Release - Cluster of Coronavirus Disease Associated with Fitness Dance Classes, South Korea - Volume 26, Number 8—August 2020 - Emerging Infectious Diseases journal - CDC
  • 05/20 Nasal ACE2 Levels and COVID-19 in Children | Infectious Diseases | JAMA | JAMA Network
  • 05/25 Tail risk of contagious diseases | Nature Physics
  • 05/29 Differential Effects of Intervention Timing on COVID-19 Spread in the United States | medRxiv

    June 2020

  • 06/01 Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis - The Lancet
  • 06/03 Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review: Annals of Internal Medicine: Vol 0, No 0
  • 06/04 Serodiagnostics for Severe Acute Respiratory Syndrome–Related Coronavirus-2: A Narrative Review: Annals of Internal Medicine: Vol 0, No 0
  • 06/05 False Negative Tests for SARS-CoV-2 Infection — Challenges and Implications | NEJM
  • 06/08 The effect of large-scale anti-contagion policies on the COVID-19 pandemic | Nature discussed here: 06/08 Emergency COVID-19 measures prevented more than 500 million infections, study finds | Berkeley News
  • 06/09 Rationing social contact during the COVID-19 pandemic: Transmission risk and social benefits of US locations | PNAS discussed here: 06/11 Which businesses should be open? | MIT News
  • 06/10 A modelling framework to assess the likely effectiveness of facemasks in combination with ‘lock-down’ in managing the COVID-19 pandemic | Proceedings of the Royal Society A: Mathematical, Physical and Engineering Sciences
  • 06/10 Identifying airborne transmission as the dominant route for the spread of COVID-19 | PNAS
  • 06/11 Eurosurveillance | SARS-CoV-2 infection in farmed minks, the Netherlands, April and May 2020
  • 06/11 Identifying airborne transmission as the dominant route for the spread of COVID-19 | PNAS
  • 06/16 Community Use Of Face Masks And COVID-19: Evidence From A Natural Experiment Of State Mandates In The US | Health Affairs
  • 06/18 Cerebral Venous Thrombosis Associated with COVID-19 | American Journal of Neuroradiology
  • 06/18 Economic Vulnerability of Households With Essential Workers | Health Disparities | JAMA | JAMA Network
  • 06/22 Using influenza surveillance networks to estimate state-specific prevalence of SARS-CoV-2 in the United States | Science Translational Medicine
  • 06/22 Early Release - Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions - Volume 26, Number 9—September 2020 - Emerging Infectious Diseases journal - CDC
  • 06/29 Seroconversion of a city: Longitudinal monitoring of SARS-CoV-2 seroprevalence in New York City | medRxiv
  • 06/29 Multisystem Inflammatory Syndrome in U.S. Children and Adolescents | NEJM
  • 06/29 Multisystem Inflammatory Syndrome in Children in New York State | NEJM

    July 2020

  • 07/02 Eurosurveillance | Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020
  • 07/02 The implications of silent transmission for the control of COVID-19 outbreaks | PNAS
  • 07/06 Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study - The Lancet
  • 07/09 Persistent Symptoms in Patients After Acute COVID-19 | Critical Care Medicine | JAMA | JAMA Network
  • 07/09 Socio-economic, environmental impacts of COVID-19 quantified
  • 07/09 Air recirculation role in the infection with COVID-19, lessons learned from Diamond Princess cruise ship | medRxiv
  • 07/10 Tracking the reach of COVID-19 kin loss with a bereavement multiplier applied to the United States | PNAS
  • 07/11 Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection | medRxiv
  • 07/14 An Mrna Vaccine Against Sars Cov 2 — Preliminary Report articles: NEJM.org
  • 07/15 Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial. | medRxiv
  • 07/16 Reconstruction of the full transmission dynamics of COVID-19 in Wuhan | Nature
  • 07/16 Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study - The Lancet Public Health
  • 07/21 The Infectious Nature of Patient-Generated SARS-CoV-2 Aerosol | medRxiv
  • 07/28 Social distancing responses to COVID-19 emergency declarations strongly differentiated by income | PNAS
  • 07/29 Association Between Statewide School Closure and COVID-19 Incidence and Mortality in the US | Infectious Diseases | JAMA | JAMA Network
  • 07/29 Characteristics and Quality of US Nursing Homes Reporting Cases of Coronavirus Disease 2019 (COVID-19) | Geriatrics | JAMA Network Open | JAMA Network

    August 2020

  • 08/01 Long-term patient-reported symptoms of COVID-19: an analysis of social media data | medRxiv
  • 08/03 Use of facemasks during the COVID-19 pandemic - The Lancet Respiratory Medicine
  • 08/04 Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients | medRxiv
  • 08/06 Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea | Infectious Diseases | JAMA Internal Medicine | JAMA Network
  • 08/07 Low-cost measurement of facemask efficacy for filtering expelled droplets during speech | Science Advances
  • 08/07 Interferon responses in viral pneumonias | Science
  • 08/07 Successful Elimination of Covid-19 Transmission in New Zealand | NEJM
  • 08/10 Dental procedure aerosols and COVID-19 - The Lancet Infectious Diseases
  • 08/11 Management of post-acute covid-19 in primary care | The BMJ
  • 08/13 Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2 | medRxiv
  • 08/18 Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure | Annals of Internal Medicine
  • 08/19 Demographic perspectives on the mortality of COVID-19 and other epidemics | PNAS
  • 08/19 Social and behavioral consequences of mask policies during the COVID-19 pandemic | PNAS
  • 08/19 Characterizing superspreading events and age-specific infectiousness of SARS-CoV-2 transmission in Georgia, USA | PNAS
  • 08/21 COVID-19 is, in the end, an endothelial disease | European Heart Journal | Oxford Academic
  • 08/21 Efficacy of Remdesivir in COVID-19 | Infectious Diseases | JAMA | JAMA Network
  • 08/21 Early Release - Asymptomatic Transmission of SARS-CoV-2 on Evacuation Flight - Volume 26, Number 11—November 2020 - Emerging Infectious Diseases journal - CDC
  • 08/24 Full article: Exhaled respiratory particles during singing and talking
  • 08/26 Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis - Clinical Microbiology and Infection
  • 08/26 Population-scale longitudinal mapping of COVID-19 symptoms, behaviour and testing | Nature Human Behaviour
  • 08/27 Misconceptions about weather and seasonality must not misguide COVID-19 response | Nature Communications
  • 08/28 Salivary Detection of COVID-19 | Annals of Internal Medicine
  • 08/28 Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2 | NEJM

    September 2020

  • 09/02 Reduced development of COVID-19 in children reveals molecular checkpoints gating pathogenesis illuminating potential therapeutics | PNAS
  • 09/04 An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction | Nature Communications
  • 09/08 Comparison of Clinical Features of COVID-19 vs Seasonal Influenza A and B in US Children | Infectious Diseases | JAMA Network Open | JAMA Network
  • 09/08 “When Will We Have a Vaccine?” — Understanding Questions and Answers about Covid-19 Vaccination | NEJM
  • 09/08 Facial Masking for Covid-19 — Potential for “Variolation” as We Await a Vaccine | NEJM
  • 09/08 Social and behavioral consequences of mask policies during the COVID-19 pandemic | PNAS
  • 09/08 Demographic perspectives on the mortality of COVID-19 and other epidemics | PNAS
  • 09/09 Clinical Outcomes in Young US Adults Hospitalized With COVID-19 | Critical Care Medicine | JAMA Internal Medicine | JAMA Network
  • 09/09 Use of “normal” risk to improve understanding of dangers of covid-19 | The BMJ
  • 09/09 Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score | The BMJ
  • 09/09 Covid-19 Molecular Diagnostic Testing — Lessons Learned | NEJM
  • 09/10 Trained Innate Immunity, Epigenetics, and Covid-19 | NEJM
  • 09/10 Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study - The Lancet
  • 09/11 COVID-19 and the Path to Immunity | Allergy and Clinical Immunology | JAMA | JAMA Network
  • 09/11 Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection | Infectious Diseases | JAMA Cardiology | JAMA Network
  • 09/14 Seasonal coronavirus protective immunity is short-lasting | Nature Medicine
  • 09/17 Patient-reported outcome measures after COVID-19: a prospective cohort study | European Respiratory Society
  • 09/17 A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity | Nature Communications
  • 09/17 Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong | Nature Medicine
  • 09/18 Artificial intelligence in COVID-19 drug repurposing - The Lancet Digital Health
  • 09/21 COVID-19 in children and young people | Science
  • 09/21 Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients | Science Translational Medicine
  • 09/22 Quantifying and contextualizing the impact of bioRxiv preprints through automated social media audience segmentation
  • 09/22 Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis - PLOS
  • 09/23 National Trends of Cases of COVID-19 in Children Based on US State Health Department Data | American Academy of Pediatrics
  • 09/23 The rise of COVID-19 cases is associated with support for world leaders | PNAS
  • 09/23 Physics of virus transmission by speaking droplets | PNAS
  • 09/25 Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults: A Systematic Review and Meta-analysis | Adolescent Medicine | JAMA Pediatrics | JAMA Network
  • 09/25 Speech can produce jet-like transport relevant to asymptomatic spreading of virus | PNAS
  • 09/25 Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation | PNAS
  • 09/25 Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study - The Lancet
  • 09/28 Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity | Science
  • 09/28 Effects of ventilation on the indoor spread of COVID-19 | Journal of Fluid Mechanics | Cambridge Core
  • 09/28 Direct detection of SARS-CoV-2 using CRISPR-Cas13a and a mobile phone | medRxiv
  • 09/29 Epidemiology and transmission dynamics of COVID-19 in two Indian states | Science
  • 09/29 A Cytokine Circus with a Viral Ringleader: SARS-CoV-2-Associated Cytokine Storm Syndromes: Trends in Molecular Medicine - Cell
  • 09/29 Genetic mechanisms of critical illness in Covid-19 | medRxiv
  • 09/29 Low risk of SARS-CoV-2 transmission by fomites in real-life conditions - The Lancet Infectious Diseases
  • 09/29 Early Release - Flight-Associated Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Corroborated by Whole-Genome Sequencing - Volume 26, Number 12—December 2020 - Emerging Infectious Diseases journal - CDC
  • 09/30 In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study | The BMJ
  • 09/30 Spinal cord dysfunction after COVID-19 infection - Nature

    October 2020

  • 10/01 Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study - PLOS
  • 10/01 COVID-19 Vaccine Predictions: Using Mathematical Modelling and Expert Opinions to Estimate Timelines and Probabilities of Success of COVID-19 Vaccines | Center For Global Development
  • 10/01 Frontiers | Pandemic Dreams: Network Analysis of Dream Content During the COVID-19 Lockdown | Psychology
  • 10/02 Airborne transmission of SARS-CoV-2 | Science
  • 10/05 Long-term Health Consequences of COVID-19 | Cardiology | JAMA | JAMA Network
  • 10/05 Follow-up of adults with non-critical COVID-19 two months after symptoms' onset - ScienceDirect
  • 10/05 Neuropathology of patients with COVID-19 in Germany: a post-mortem case series - The Lancet Neurology
  • 10/06 Children and Adolescents With SARS-CoV-2 Infection Epidemiology, Clinical Course and Viral Loads - The Pediatric Infectious Disease Journal
  • 10/06 Symptoms and Transmission of SARS-CoV-2 among Children—Utah and Wisconsin, March–May 2020 | American Academy of Pediatrics
  • 10/06 SARS-CoV-2-specific T-cells in unexposed humans: presence of cross-reactive memory cells does not equal protective immunity | Signal Transduction and Targeted Therapy
  • 10/06 Cross-reactive memory T cells and herd immunity to SARS-CoV-2 | Nature Reviews Immunology
  • 10/06 Characteristics of SARS-CoV-2 and COVID-19 | Nature Reviews Microbiology
  • 10/06 Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases | PNAS
  • 10/07 The effect of temperature on persistence of SARS-CoV-2 on common surfaces | Virology Journal | Full Text
  • 10/07 Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19 | Nature Immunology
  • 10/08 Characteristics of Hospitalized Children With SARS-CoV-2 in the New York City Metropolitan Area - PubMed
  • 10/08 SARS-CoV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses: Cell
  • 10/08 Remdesivir for the Treatment of Covid-19 — Final Report | NEJM
  • 10/08 Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study - The Lancet Respiratory Medicine
  • 10/09 Economic hardship and mental health complaints during COVID-19 | PNAS
  • 10/10 Convalescent plasma for patients with severe COVID-19: a matched cohort study | Clinical Infectious Diseases | Oxford Academic
  • 10/11 Global projections of potential lives saved from COVID-19 through universal mask use | medRxiv
  • 10/12 Excess Deaths From COVID-19 and Other Causes, March-July 2020 | Cardiology | JAMA | JAMA Network
  • 10/12 Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York City | Infectious Diseases | JAMA Pediatrics | JAMA Network
  • 10/12 SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies | Nature
  • 10/12 The role of environmental factors on transmission rates of the COVID-19 outbreak: an initial assessment in two spatial scales | Scientific Reports - Nature
  • 10/12 Seasonality and uncertainty in global COVID-19 growth rates | PNAS
  • 10/12 Genomic evidence for reinfection with SARS-CoV-2: a case study - The Lancet Infectious Diseases
  • 10/13 Sudden irreversible hearing loss post COVID-19 | BMJ Case Reports
  • 10/13 Regeneron’s Antibodies Prevent and Treat SARS-CoV-2 Infection in Monkeys
  • 10/13 SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates - The Lancet
  • 10/13 COVID-19 in New Zealand and the impact of the national response: a descriptive epidemiological study - The Lancet Public Health
  • 10/15 Synthesis and systematic review of reported neonatal SARS-CoV-2 infections | Nature Communications
  • 10/16 Emergency Use Authorization of Covid Vaccines — Safety and Efficacy Follow-up Considerations | NEJM
  • 10/19 Herd Immunity and Implications for SARS-CoV-2 Control | JAMA | JAMA Network
  • 10/19 Asymptomatic and Presymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates in a Multistate Sample of Skilled Nursing Facilities | Geriatrics | JAMA Internal Medicine | JAMA Network
  • 10/19 Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity | Science
  • 10/19 Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate | Science
  • 10/20 Numerical investigation of aerosol transport in a classroom with relevance to COVID-19: Physics of Fluids: Vol 32, No 10
  • 10/20 Building Trust to Achieve Confidence in COVID-19 Vaccines | Infectious Diseases | JAMA Network Open | JAMA Network
  • 10/20 Factors Associated With US Adults’ Likelihood of Accepting COVID-19 Vaccination | Infectious Diseases | JAMA Network Open | JAMA Network
  • 10/20 Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study | The BMJ
  • 10/20 Eurosurveillance | A large national outbreak of COVID-19 linked to air travel, Ireland, summer 2020 - Eurosurveillance
  • 10/21 Early Release - Susceptibility of Raccoon Dogs for Experimental SARS-CoV-2 Infection - Volume 26, Number 12—December 2020 - Emerging Infectious Diseases journal - CDC
  • 10/22 Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) | The BMJ
  • 10/23 Trends in COVID-19 Risk-Adjusted Mortality Rates | Journal of Hospital Medicine
  • 10/24 Identification of required host factors for SARS-CoV-2 infection in human cells: Cell
  • 10/26 Preventing the Spread of SARS-CoV-2 With Masks and Other “Low-tech” Interventions | Infectious Diseases | JAMA | JAMA Network
  • 10/26 Return to Play for Athletes After Coronavirus Disease 2019 Infection—Making High-Stakes Recommendations as Data Evolve | Infectious Diseases | JAMA Cardiology | JAMA Network
  • 10/26 Coronavirus Disease 2019 and the Athletic Heart: Emerging Perspectives on Pathology, Risks, and Return to Play | Infectious Diseases | JAMA Cardiology | JAMA Network
  • 10/26 Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans | Nature Microbiology
  • 10/27 Aerosol persistence in relation to possible transmission of SARS-CoV-2: Physics of Fluids: Vol 32, No 10
  • 10/27 COVID-19 associated arterial ischaemic stroke and multisystem inflammatory syndrome in children: a case report - The Lancet Child & Adolescent Health
  • 10/27 What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2 - The Lancet Infectious Diseases
  • 10/28 Risk of hospital admission with coronavirus disease 2019 in healthcare workers and their households: nationwide linkage cohort study | The BMJ
  • 10/28 Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19: Cell
  • 10/28 SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19 | NEJM
  • 10/29 Wearable sensor data and self-reported symptoms for COVID-19 detection | Nature Medicine
  • 10/30 Association between SARS-CoV-2 infection, exposure risk and mental health among a cohort of essential retail workers in the USA | Occupational & Environmental Medicine
  • 10/30 The Effects of Large Group Meetings on the Spread of COVID-19: The Case of Trump Rallies by B. Douglas Bernheim, Nina Buchmann, Zach Freitas-Groff, Sebastián Otero :: SSRN
  • 10/30 SARS-CoV-2 direct cardiac damage through spike-mediated cardiomyocyte fusion | Research Square

    November 2020

  • 11/02 Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19 | Science Translational Medicine
  • 11/02 Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection | bioRxiv
  • 11/03 Dispersion of evaporating cough droplets in tropical outdoor environment: Physics of Fluids: Vol 32, No 11
  • 11/03 Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production: Cell
  • 11/03 Revealing fine-scale spatiotemporal differences in SARS-CoV-2 introduction and spread | Nature Communications
  • 11/03 Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City | Nature
  • 11/04 Lack of antibodies to SARS-CoV-2 in a large cohort of previously infected persons | Clinical Infectious Diseases | Oxford Academic
  • 11/04 An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike | Science
  • 11/04 Case Study: Prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised cancer patient.: Cell
  • 11/04 High Prevalence of Pericardial Involvement in College Student-Athletes Recovering From COVID-19 | JACC: Cardiovascular Imaging
  • 11/05 Differential effects of intervention timing on COVID-19 spread in the United States | Science Advances
  • 11/05 Preexisting and de novo humoral immunity to SARS-CoV-2 in humans | Science
  • 11/05 Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum | Nature Immunology
  • 11/06 Acute Kidney Injury in a National Cohort of Hospitalized US Veterans with COVID-19 | American Society of Nephrology
  • 11/06 Epidemiology and transmission dynamics of COVID-19 in two Indian states | Science
  • 11/09 Real-time, interactive website for US-county-level COVID-19 event risk assessment | Nature Human Behaviour
  • 11/09 Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids | Nature Medicine
  • 11/09 Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance - The Lancet Child & Adolescent Health
  • 11/10 Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration | Vaccination | JAMA Internal Medicine | JAMA Network
  • 11/10 Mobility network models of COVID-19 explain inequities and inform reopening | Nature
  • 11/11 Sixty-Day Outcomes Among Patients Hospitalized With COVID-19 | Annals of Internal Medicine
  • 11/11 Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers | Nature Structural & Molecular Biology
  • 11/12 The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19) | Scientific Reports
  • 11/13 Enhancing host cell infection by SARS-CoV-2 | Science
  • 11/13 Real-time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles: Cell Host & Microbe
  • 11/13 SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 are Expressed in the Microvasculature and Ducts of Human Pancreas but are Not Enriched in β Cells: Cell Metabolism
  • 11/14 Staying sane in our new COVID-19 world - The Lancet
  • 11/16 Trends in Outpatient Care Delivery and Telemedicine During the COVID-19 Pandemic in the US | Infectious Diseases | JAMA Internal Medicine | JAMA Network
  • 11/16 Diaphragm Pathology in Critically Ill Patients With COVID-19 and Postmortem Findings From 3 Medical Centers | Critical Care Medicine | JAMA Internal Medicine | JAMA Network
  • 11/16 COVID-19-associated Non-Occlusive Fibrin Microthrombi in the Heart | Circulation
  • 11/16 Immunological memory to SARS-CoV-2 assessed for greater than six months after infection | bioRxiv
  • 11/16 Ranking the effectiveness of worldwide COVID-19 government interventions | Nature Human Behaviour
  • 11/17 Ensuring vaccine safety | Science
  • 11/17 Expecting the unexpected with COVID-19 vaccines - The Lancet Infectious Diseases
  • 11/18 The known unknowns of T cell immunity to COVID-19 | Science Immunology
  • 11/18 Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers: A Randomized Controlled Trial: Annals of Internal Medicine: Vol 0, No 0 - ACP Journals
  • 11/18 COVID-19-associated olfactory dysfunction reveals SARS-CoV-2 neuroinvasion and persistence in the olfactory system | bioRxiv
  • 11/18 Antibodies to SARS-CoV-2 are associated with protection against reinfection | medRxiv
  • 11/18 Pre-symptomatic detection of COVID-19 from smartwatch data | Nature Biomedical Engineering
  • 11/18 Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19 | Nature Immunology
  • 11/18 Event-specific interventions to minimize COVID-19 transmission | PNAS
  • 11/18 Age and frailty in COVID-19 vaccine development - The Lancet
  • 11/19 Ct values and infectivity of SARS-CoV-2 on surfaces - The Lancet Infectious Diseases
  • 11/19 SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis - The Lancet Microbe
  • 11/20 Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening | Science Advances
  • 11/20 Air-Filtering Masks for Respiratory Protection from PM2.5 and Pandemic Pathogens: One Earth
  • 11/23 Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2 | Science
  • 11/23 Functional SARS-CoV-2-specific immune memory persists after mild COVID-19: Cell
  • 11/24 Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020 | Infectious Diseases | JAMA Internal Medicine | JAMA Network
  • 11/24 Antibodies, Immunity, and COVID-19 | Infectious Diseases | JAMA Internal Medicine | JAMA Network
  • 11/24 SARS-CoV-2 receptors and entry genes are expressed in the human olfactory neuroepithelium and brain: iScience
  • 11/24 A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19 | NEJM
  • 11/24 A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia | NEJM
  • 11/24 Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion | PNAS
  • 11/26 Nucleic Acid-Based Technologies Targeting Coronaviruses: Trends in Biochemical Sciences
  • 11/26 Rethinking Covid-19 Test Sensitivity — A Strategy for Containment | NEJM
  • 11/27 Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate | Science
  • 11/27 SARS-CoV-2 and the risk of Parkinson's disease: facts and fantasy - The Lancet Neurology
  • 11/28 The effectiveness of population-wide, rapid antigen test based screening in reducing SARS-CoV-2 infection prevalence in Slovakia | CMMID Repository
  • 11/28 A tribute to some of the doctors who died from COVID-19 - The Lancet
  • 11/30 Frontiers | Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection | Immunology
  • 11/30 COVID-19 in a case previously infected with MERS-CoV: No cross immunity - Journal of Infection
  • 11/30 Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19 | Nature Neuroscience

    December 2020

  • 12/01 Post-infectious inflammatory disease in MIS-C features elevated cytotoxicity signatures and autoreactivity that correlates with severity | medRxiv
  • 12/01 Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer | NEJM
  • 12/02 Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results - PubMed
  • 12/02 Reversible Myocardial Injury Associated With SARS-CoV-2 in an Infant | JACC: Case Reports
  • 12/02 Placebo-Controlled Trials of Covid-19 Vaccines — Why We Still Need Them | NEJM
  • 12/03 Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19 - PubMed
  • 12/03 Fast detection of SARS-CoV-2 RNA via the integration of plasmonic thermocycling and fluorescence detection in a portable device | Nature Biomedical Engineering
  • 12/03 Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host | NEJM
  • 12/03 Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination | NEJM
  • 12/03 Cytokine Storm | NEJM
  • 12/04 Amplification-free detection of SARS-CoV-2 with CRISPR-Cas13a and mobile phone microscopy: Cell
  • 12/04 Correlates of protection against SARS-CoV-2 in rhesus macaques | Nature
  • 12/04 Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison | Nature Immunology
  • 12/07 IgA dominates the early neutralizing antibody response to SARS-CoV-2 | Science Translational Medicine
  • 12/07 Enhanced SARS-CoV-2 neutralization by dimeric IgA | Science Translational Medicine
  • 12/07 Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis | The BMJ
  • 12/07 Model-informed COVID-19 vaccine prioritization strategies by age and serostatus | medRxiv
  • 12/07 Effect of internationally imported cases on internal spread of COVID-19: a mathematical modelling study - The Lancet Public Health
  • 12/08 iGenomics: Comprehensive DNA sequence analysis on your Smartphone | GigaScience | Oxford Academic
  • 12/08 Effect of sneezing on the flow around a face shield: Physics of Fluids: Vol 32, No 12
  • 12/08 Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic | Science
  • 12/08 Simultaneous COVID-19 in Homozygous Twins | Annals of Internal Medicine
  • 12/08 Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Randomized Trial: Annals of Internal Medicine: Vol 0, No 0
  • 12/08 Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet
  • 12/08 SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England - The Lancet Infectious Diseases
  • 12/09 Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants | Occupational & Environmental Medicine
  • 12/09 Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2 | Science Translational Medicine
  • 12/10 Evaluation of Cloth Masks and Modified Procedure Masks as Personal Protective Equipment for the Public During the COVID-19 Pandemic | Infectious Diseases | JAMA Internal Medicine | JAMA Network
  • 12/10 Using Cardiovascular Cells from Human Pluripotent Stem Cells for COVID-19 Research: Why the Heart Fails: Stem Cell Reports
  • 12/11 The kinetics of humoral response and its relationship with the disease severity in COVID-19 | Communications Biology
  • 12/11 Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2 | PNAS
  • 12/12 Is my cough COVID-19? - The Lancet
  • 12/13 SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome | bioRxiv
  • 12/14 Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis | Global Health | JAMA Network Open | JAMA Network
  • 12/15 Effects of mask-wearing on the inhalability and deposition of airborne SARS-CoV-2 aerosols in human upper airway: Physics of Fluids: Vol 32, No 12
  • 12/15 Effects of space sizes on the dispersion of cough-generated droplets from a walking person: Physics of Fluids: Vol 32, No 12
  • 12/15 COVID-19 neutralizing antibodies predict disease severity and survival: Cell
  • 12/15 Nursing home staff networks and COVID-19 | PNAS
  • 12/15 Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study - The Lancet Child & Adolescent Health
  • 12/15 SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study - The Lancet Infectious Diseases
  • 12/16 All-Cause Excess Mortality and COVID-19–Related Mortality Among US Adults Aged 25-44 Years, March-July 2020 | Infectious Diseases | JAMA | JAMA Network
  • 12/16 The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice | Nature Neuroscience
  • 12/16 Emergence of a Highly Fit SARS-CoV-2 Variant | NEJM
  • 12/17 COVID-19 Myocardial Pathology Evaluation in AthleTEs with Cardiac Magnetic Resonance (COMPETE CMR) | Circulation
  • 12/17 A Crisp(r) New Perspective on SARS-CoV-2 Biology: Cell
  • 12/17 Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses | Nature Medicine
  • 12/17 T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial | Nature Medicine
  • 12/17 Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study - The Lancet Respiratory Medicine
  • 12/18 Kinetics of antibody responses dictate COVID-19 outcome | medRxiv
  • 12/18 Infectivity of asymptomatic versus symptomatic COVID-19 - The Lancet
  • 12/20 Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations - nCoV-2019 Genomic Epidemiology - Virological
  • 12/20 Threat Assessment Brief: Rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom - ECDC
  • 12/21 Excess Mortality in California During the Coronavirus Disease 2019 Pandemic, March to August 2020 | Infectious Diseases | JAMA Internal Medicine | JAMA Network
  • 12/21 Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study - The Lancet Microbe
  • 12/22 Variation in US Hospital Mortality Rates for Patients Admitted With COVID-19 During the First 6 Months of the Pandemic | Infectious Diseases | JAMA Internal Medicine | JAMA Network
  • 12/22 Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid: Immunity
  • 12/22 COVID-19 and the Swedish enigma - The Lancet
  • 12/23 Assessment of Air Contamination by SARS-CoV-2 in Hospital Settings | Infectious Diseases | JAMA Network Open | JAMA Network
  • 12/23 SARS-CoV-2 mutations among minks show reduced lethality and infectivity to humans | bioRxiv
  • 12/23 Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers | NEJM
  • 12/24 Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact | medRxiv
  • 12/25 Reverse Engineering the source code of the BioNTech/Pfizer SARS-CoV-2 Vaccine - Articles
  • 12/25 SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity: Med
  • 12/28 One Year Later, How Does COVID-19 Affect Children? | Infectious Diseases | JAMA Pediatrics | JAMA Network
  • 12/28 Superspreading in early transmissions of COVID-19 in Indonesia | Scientific Reports
  • 12/29 Assessment of Neutrophil Extracellular Traps in Coronary Thrombus of a Case Series of Patients With COVID-19 and Myocardial Infarction | Acute Coronary Syndromes | JAMA Cardiology | JAMA Network
  • 12/29 Update Alert 4: Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings | Annals of Internal Medicine
  • 12/29 Masks and Face Coverings for the Lay Public: A Narrative Update: Annals of Internal Medicine: Vol 0, No 0
  • 12/30 Fluid dynamics of COVID-19 airborne infection suggests urgent data for a scientific design of social distancing | Scientific Reports
  • 12/30 Microvascular Injury in the Brains of Patients with Covid-19 | NEJM
  • 12/30 Neutralizing Antibody LY-CoV555 for Outpatient Covid-19 | NEJM
  • 12/30 Maintaining Safety with SARS-CoV-2 Vaccines | NEJM

    January 2021

  • 01/01 Airflows inside passenger cars and implications for airborne disease transmission | Science Advances
  • 01/02 Mutations arising in SARS-CoV-2 spike on sustained human-to-human transmission and human-to-animal passage - SARS-CoV-2 coronavirus - Virological
  • 01/04 Risk Factors Associated With All-Cause 30-Day Mortality in Nursing Home Residents With COVID-19 | Dementia and Cognitive Impairment | JAMA Internal Medicine | JAMA Network
  • 01/05 Endemic SARS-CoV-2 will maintain post-pandemic immunity | Nature Reviews Immunology
  • 01/05 Early Release - Genomic Evidence of In-Flight Transmission of SARS-CoV-2 Despite Predeparture Testing - Volume 27, Number 3—March 2021 - Emerging Infectious Diseases journal - CDC
  • 01/06 Genetic Variants of SARS-CoV-2—What Do They Mean? | Infectious Diseases | JAMA | JAMA Network
  • 01/06 Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection | Science
  • 01/07 The value of decreasing the duration of the infectious period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection - PLOS
  • 01/07 COVID-19 vasculitis and novel vasculitis mimics - The Lancet Rheumatology
  • 01/08 A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis | Science
  • 01/08 Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK | Science
  • 01/08 Findings from Cardiovascular Evaluation of NCAA Division I Collegiate Student-Athletes after Asymptomatic or Mildly Symptomatic SARS-CoV-2 Infection | medRxiv
  • 01/11 Immunological characteristics govern the transition of COVID-19 to endemicity | Science
  • 01/11 Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice | Science
  • 01/11 A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection | Nature Genetics
  • 01/11 The distribution of cellular turnover in the human body | Nature Medicine
  • 01/11 Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals | Nature Medicine
  • 01/11 A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent | Nature Structural & Molecular Biology
  • 01/11 Retail store customer flow and COVID-19 transmission | PNAS
  • 01/12 MuSK Antibody–Associated Myasthenia Gravis With SARS-CoV-2 Infection: A Case Report | Annals of Internal Medicine
  • 01/12 The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs: A Systematic Review and Meta-analysis: Annals of Internal Medicine: Vol 0, No 0 - ACP Journals
  • 01/12 Adaptive immunity to SARS-CoV-2 and COVID-19: Cell
  • 01/12 First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020 - The Lancet Infectious Diseases
  • 01/13 Messenger RNA vaccines against SARS-CoV-2: Cell
  • 01/13 Immune determinants of COVID-19 disease presentation and severity | Nature Medicine
  • 01/13 Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19 | NEJM
  • 01/13 Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine | NEJM
  • 01/14 Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging | Cardiology | JAMA Cardiology | JAMA Network
  • 01/14 SARS-CoV-2 antibody testing for estimating COVID-19 prevalence in the population: Cell Reports Medicine
  • 01/14 Long COVID in the skin: a registry analysis of COVID-19 dermatological duration - The Lancet Infectious Diseases
  • 01/14 Public health surveillance of infectious diseases: beyond point mutations - The Lancet Microbe
  • 01/15 Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2: A Systematic Review and Meta-analysis | Infectious Diseases | JAMA Internal Medicine | JAMA Network
  • 01/15 Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness | medRxiv
  • 01/15 Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data - The Lancet Respiratory Medicine
  • 01/18 Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19 - PubMed
  • 01/18 Sociodemographic disparities in energy insecurity among low-income households before and during the COVID-19 pandemic | Nature Energy
  • 01/18 Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study - The Lancet Infectious Diseases
  • 01/19 mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants | bioRxiv
  • 01/19 Vaccinology in the post−COVID-19 era | PNAS
  • 01/19 Mask-wearing and control of SARS-CoV-2 transmission in the USA: a cross-sectional study - The Lancet Digital Health
  • 01/21 Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8+ T cells | Science Immunology
  • 01/21 Model-informed COVID-19 vaccine prioritization strategies by age and serostatus | Science
  • 01/21 Optimizing age-specific vaccination | Science
  • 01/22 Sex differences in immune responses | Science
  • 01/22 Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody | Science
  • 01/22 The Proportion of SARS-CoV-2 Infections That Are Asymptomatic: A Systematic Review: Annals of Internal Medicine: Vol 0, No 0
  • 01/23 B cell memory: understanding COVID-19: Immunity
  • 01/25 Global absence and targeting of protective immune states in severe COVID-19 | Nature
  • 01/25 Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis | Nature
  • 01/25 Early warnings of COVID-19 outbreaks across Europe from social media | Scientific Reports
  • 01/26 A novel SARS-CoV-2 related coronavirus in bats from Cambodia | bioRxiv
  • 01/26 Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases: Cell Reports Medicine
  • 01/26 Antibodies, epicenter of SARS-CoV-2 immunology | Cell Death & Differentiation
  • 01/26 An evidence review of face masks against COVID-19 | PNAS
  • 01/27 The case against delaying SARS-CoV-2 mRNA vaccine boosting doses | Clinical Infectious Diseases | Oxford Academic
  • 01/27 Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K, and N501Y variants by BNT162b2 vaccine-elicited sera | bioRxiv
  • 01/27 Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19 | NEJM
  • 01/27 Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence - The Lancet
  • 01/28 Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera | Science
  • 01/28 Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity: Cell
  • 01/28 SARS-CoV-2 testing for public health use: core principles and considerations for defined use settings - The Lancet Global Health
  • 01/29 Translating viral vaccines into immunity | Science
  • 01/29 Insights from SARS-CoV-2 sequences | Science
  • 01/29 Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response: Cell Host & Microbe
  • 01/29 Public health actions to control new SARS-CoV-2 variants: Cell
  • 01/29 Leveraging the antiviral type-I interferon system as a first line defense against SARS-CoV-2 pathogenicity: Immunity
  • 01/29 Robust spike antibody responses and increased reactogenicity in seropositive individuals after a single dose of SARS-CoV-2 mRNA vaccine | medRxiv
  • 01/30 SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses - EBioMedicine

    February 2021

  • 02/01 Age groups that sustain resurging COVID-19 epidemics in the United States | Science
  • 02/02 Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape | Science
  • 02/02 Naive human B cells can neutralize SARS-CoV-2 through recognition of its receptor binding domain | bioRxiv
  • 02/02 Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity | Nature Immunology
  • 02/02 Sixteen novel lineages of SARS-CoV-2 in South Africa | Nature Medicine
  • 02/02 Timing matters when correcting fake news | PNAS
  • 02/02 Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia - The Lancet
  • 02/02 Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study - The Lancet Infectious Diseases
  • 02/02 Understanding the drivers of transmission of SARS-CoV-2 - The Lancet Infectious Diseases
  • 02/03 Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents | Nature Biotechnology
  • 02/03 SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas | Nature Metabolism
  • 02/04 Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19: A Randomized Clinical Trial | Infectious Diseases | JAMA Otolaryngology–Head & Neck Surgery | JAMA Network
  • 02/04 Comparative cost-effectiveness of SARS-CoV-2 testing strategies in the USA: a modelling study - The Lancet Public Health
  • 02/05 Cardiac arrest occurrence during successive waves of the COVID-19 pandemic: direct and indirect consequences | European Heart Journal | Oxford Academic
  • 02/05 Antibodies elicited by SARS-CoV-2 infection and boosted by vaccination neutralize an emerging variant and SARS-CoV-1 | medRxiv
  • 02/05 SARS-CoV-2 evolution during treatment of chronic infection | Nature
  • 02/05 COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics - The Lancet Public Health
  • 02/05 Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial - The Lancet Respiratory Medicine
  • 02/07 Genomic epidemiology identifies emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States | medRxiv
  • 02/08 Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies: Cell Host & Microbe
  • 02/08 SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study - The Lancet Child & Adolescent Health
  • 02/09 Simulation-based study of COVID-19 outbreak associated with air-conditioning in a restaurant: Physics of Fluids: Vol 33, No 2
  • 02/09 Prevalence and Outcomes of SARS-CoV-2 Infection Among Migrant Workers in Singapore | Global Health | JAMA | JAMA Network
  • 02/09 Public Health Interventions, Epidemic Growth, and Regional Variation of the 1918 Influenza Pandemic Outbreak in a Swiss Canton and Its Greater Regions | Annals of Internal Medicine
  • 02/09 A SARS-CoV-2 Cluster in an Acute Care Hospital | Annals of Internal Medicine
  • 02/09 Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection: Cell
  • 02/09 COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses: Immunity
  • 02/09 Poor antigen-specific responses to the second BNT162b2 mRNA vaccine dose in SARS-CoV-2-experienced individuals | medRxiv
  • 02/09 COVID-19 Modeling and the Path to Herd Immunity - Medscape
  • 02/09 The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome | PNAS
  • 02/10 Severe reinfection with South African SARS-CoV-2 variant 501Y.V2: A case report | Clinical Infectious Diseases | Oxford Academic
  • 02/10 Effectiveness of Mask Wearing to Control Community Spread of SARS-CoV-2 | Infectious Diseases | JAMA | JAMA Network
  • 02/10 Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa | medRxiv
  • 02/10 Public policy and health in the Trump era - The Lancet
  • 02/10 Effect of the new SARS-CoV-2 variant B.1.1.7 on children and young people - The Lancet Child & Adolescent Health
  • 02/11 The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types | eLife
  • 02/11 Emergence of a Novel SARS-CoV-2 Variant in Southern California | Public Health | JAMA | JAMA Network
  • 02/11 The role of children in the spread of COVID-19: Using household data from Bnei Brak, Israel, to estimate the relative susceptibility and infectivity of children - PLOS
  • 02/11 Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors - PLOS
  • 02/11 Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study | The BMJ
  • 02/11 Hydrating the respiratory tract: an alternative explanation why masks lower severity of COVID-19: Biophysical Journal
  • 02/12 Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021 | Allergy and Clinical Immunology | JAMA | JAMA Network
  • 02/12 Assessing Brain Capillaries in Coronavirus Disease 2019 | Infectious Diseases | JAMA Neurology | JAMA Network
  • 02/12 Single-domain antibodies make a difference | Science
  • 02/12 Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice | Science
  • 02/12 A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection | bioRxiv
  • 02/12 Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection: Cell
  • 02/15 Viral load of SARS-CoV-2 in adults during the first and second wave of COVID-19 pandemic in Houston, TX: the potential of the super-spreader | The Journal of Infectious Diseases | Oxford Academic
  • 02/15 OSF Preprints | Superspreaders drive the largest outbreaks of hospital onset COVID-19 infection
  • 02/15 Diagnostics for SARS-CoV-2 infections | Nature Materials
  • 02/15 Interleukin-6 Receptor Inhibition in Covid-19 — Cooling the Inflammatory Soup | NEJM
  • 02/16 Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2 - Harvard
  • 02/16 Ocular MRI Findings in Patients with Severe COVID-19: A Retrospective Multicenter Observational Study | Radiology
  • 02/16 COVID-19 and the human innate immune system: Cell
  • 02/17 Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study | SpringerLink
  • 02/17 Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets | Science
  • 02/17 Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | NEJM
  • 02/17 Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine — Preliminary Report | NEJM
  • 02/18 Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera: Cell
  • 02/18 Circulating SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity | medRxiv
  • 02/18 Could mutations of SARS-CoV-2 suppress diagnostic detection? | Nature Biotechnology
  • 02/19 Immunogenicity of clinically relevant SARS-CoV-2 vaccines in non-human primates and humans | Science Advances
  • 02/19 SARS-CoV-2 Positivity on or After 9 Days Among Quarantined Student Contacts of Confirmed Cases | Infectious Diseases | JAMA | JAMA Network
  • 02/19 Sequelae in Adults at 6 Months After COVID-19 Infection | Infectious Diseases | JAMA Network Open | JAMA Network
  • 02/19 Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection | Leukemia | Nature
  • 02/19 Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet
  • 02/19 Delayed-onset myocarditis following COVID-19 - The Lancet Respiratory Medicine
  • 02/23 Relationship between human exhalation diffusion and posture in face-to-face scenario with utterance: Physics of Fluids: Vol 33, No 2
  • 02/23 Viral load and contact heterogeneity predict SARS-CoV-2 transmission and super-spreading events | eLife
  • 02/23 Prolonged evolution of the human B cell response to SARS-CoV-2 infection | Science Immunology
  • 02/23 SARS-CoV-2 lineage B.1.526 emerging in the New York region detected by software utility created to query the spike mutational landscape | bioRxiv
  • 02/23 Extremely potent human monoclonal antibodies from COVID-19 convalescent patients: Cell
  • 02/23 Mechanistic transmission modeling of COVID-19 on the Diamond Princess cruise ship demonstrates the importance of aerosol transmission | PNAS
  • 02/23 Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort | PNAS
  • 02/23 Pandemic precarity: COVID-19 is exposing and exacerbating inequalities in the American heartland | PNAS
  • 02/23 Exhaled aerosol increases with COVID-19 infection, age, and obesity | PNAS
  • 02/24 Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection - Authorea
  • 02/24 BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting | NEJM
  • 02/25 Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals - The Lancet
  • 02/25 Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine - The Lancet
  • 02/26 SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis | JACC: Basic to Translational Science
  • 02/26 SARS-CoV-2 spike D614G change enhances replication and transmission | Nature

    March 2021

  • 03/01 Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2 | Vaccination | JAMA | JAMA Network
  • 03/01 COVID-19 -- exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study | Wellcome Open Research
  • 03/01 Negligible impact of SARS-CoV-2 variants on CD4+ and CD8+ T cell reactivity in COVID-19 exposed donors and vaccinees | bioRxiv
  • 03/02 Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19 | Science Immunology
  • 03/02 High-Throughput Wastewater SARS-CoV-2 Detection Enables Forecasting of Community Infection Dynamics in San Diego County | mSystems
  • 03/02 Increased Resistance of SARS-CoV-2 Variant P.1 to Antibody Neutralization | bioRxiv
  • 03/02 ‘nAb’ the self-reactive activity in the COVID-19 combat | Signal Transduction and Targeted Therapy
  • 03/02 The prevalence of antibodies to SARS-CoV-2 among blood donors in China | Nature Communications
  • 03/02 Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics | Nature Medicine
  • 03/02 SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma | Nature Medicine
  • 03/02 Quantifying asymptomatic infection and transmission of COVID-19 in New York City using observed cases, serology, and testing capacity | PNAS
  • 03/02 The effects of school closures on SARS-CoV-2 among parents and teachers | PNAS
  • 03/02 The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2 | PNAS
  • 03/02 A genomic region associated with protection against severe COVID-19 is inherited from Neandertals | PNAS
  • 03/02 An interactive website tracking COVID-19 vaccine development - The Lancet Global Health
  • 03/03 Filtering Facepiece Respirator (N95 Respirator) Reprocessing: A Systematic Review | Infectious Diseases | JAMA | JAMA Network
  • 03/03 Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England | Science
  • 03/03 Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates | Science Translational Medicine
  • 03/03 SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines: Cell Host & Microbe
  • 03/03 Preliminary Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 Variant | medRxiv
  • 03/03 Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2 | NEJM
  • 03/03 Multisystem inflammatory syndrome in a neonate, temporally associated with prenatal exposure to SARS-CoV-2: a case report - The Lancet Child & Adolescent Health
  • 03/04 Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening | Cardiology | JAMA Cardiology | JAMA Network
  • 03/04 SARS-CoV-2 on Ocular Surfaces in a Cohort of Patients With COVID-19 From the Lombardy Region, Italy | Infectious Diseases | JAMA Ophthalmology | JAMA Network
  • 03/04 Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial - The Lancet Respiratory Medicine
  • 03/04 Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Respiratory Medicine
  • 03/04 IL-6 blockade for COVID-19: a global scientific call to arms - The Lancet Respiratory Medicine
  • 03/05 An early warning approach to monitor COVID-19 activity with multiple digital traces in near real time | Science Advances
  • 03/05 Longitudinal antibody repertoire in "mild" versus "severe" COVID-19 patients reveals immune markers associated with disease severity and resolution | Science Advances
  • 03/06 The impact of Spike mutations on SARS-CoV-2 neutralization: Cell Reports
  • 03/06 Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA Vaccination | medRxiv
  • 03/08 Acute Allergic Reactions to mRNA COVID-19 Vaccines | Allergy and Clinical Immunology | JAMA | JAMA Network
  • 03/08 Higher COVID-19 vaccination rates are linked to decreased county-level COVID-19 incidence across USA | medRxiv
  • 03/08 Long-term clinical, virological and immunological outcomes in patients hospitalized for COVID-19: antibody response predicts long COVID. | medRxiv
  • 03/08 Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2 | Nature Genetics
  • 03/08 Neutralizing Activity of BNT162b2-Elicited Serum | NEJM
  • 03/08 Clinical Characteristics, Activity Levels and Mental Health Problems in Children with Long COVID: A Survey of 510 Children[v1] | Preprints
  • 03/08 18Fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine - The Lancet
  • 03/08 Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis - The Lancet Global Health
  • 03/09 Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes | Science
  • 03/09 SARS-CoV-2 within-host diversity and transmission | Science
  • 03/09 The cytosolic DNA sensor cGAS recognizes neutrophil extracellular traps | Science Signaling
  • 03/09 Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission | Annals of Internal Medicine
  • 03/09 The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies that target both the NTD and the RBD | medRxiv
  • 03/09 Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein | Nature
  • 03/10 Impact of the COVID-19 Vaccine on Asymptomatic Infection Among Patients Undergoing Pre-Procedural COVID-19 Molecular Screening | Clinical Infectious Diseases | Oxford Academic
  • 03/10 Effectiveness of three versus six feet of physical distancing for controlling spread of COVID-19 among primary and secondary students and staff: A retrospective, state-wide cohort study | Clinical Infectious Diseases | Oxford Academic
  • 03/10 Infodemics: Do healthcare professionals detect corona-related false news stories better than students? - PLOS
  • 03/10 Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization - PubMed
  • 03/10 Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study | The BMJ
  • 03/10 Virus vaccines: proteins prefer prolines: Cell Host & Microbe
  • 03/10 The great escape? SARS-CoV-2 variants evading neutralizing responses: Cell Host & Microbe
  • 03/10 Long-Haul Post–COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrome: The Swedish Experience | JACC: Case Reports
  • 03/10 Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England | medRxiv
  • 03/10 Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial | medRxiv
  • 03/10 Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine | NEJM
  • 03/10 Children and young people remain at low risk of COVID-19 mortality - The Lancet Child & Adolescent Health
  • 03/10 Surveillance of SARS-CoV-2 in Zimbabwe shows dominance of variants of concern - The Lancet Microbe
  • 03/11 Transmission of SARS-CoV-2 from asymptomatic and presymptomatic individuals in healthcare settings despite medical masks and eye protection | Clinical Infectious Diseases | Oxford Academic
  • 03/11 What level of neutralising antibody protects from COVID-19? | medRxiv
  • 03/11 Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies | Nature
  • 03/12 Immunity to SARS-CoV-2 variants of concern | Science
  • 03/12 T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals | Science Translational Medicine
  • 03/12 Potent SARS-CoV-2 Neutralizing Antibodies Directed Against Spike N-Terminal Domain Target a Single Supersite: Cell Host & Microbe
  • 03/12 Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity: Cell
  • 03/12 Are vaccines safe in patients with Long COVID? A prospective observational study. | medRxiv
  • 03/12 Perfect as the enemy of good: tracing transmissions with low-sensitivity tests to mitigate SARS-CoV-2 outbreaks - The Lancet Microbe
  • 03/12 Could a good night's sleep improve COVID-19 vaccine efficacy? - The Lancet Respiratory Medicine
  • 03/13 Probable airborne transmission of SARS-CoV-2 in a poorly ventilated restaurant - ScienceDirect
  • 03/15 Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients | Surgery | JAMA | JAMA Network
  • 03/15 Association of Clinical, Biological, and Brain Magnetic Resonance Imaging Findings With Electroencephalographic Findings for Patients With COVID-19 | Neurology | JAMA Network Open | JAMA Network
  • 03/15 SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19 | Science Translational Medicine
  • 03/15 The first 12 months of COVID-19: a timeline of immunological insights | Nature Reviews Immunology - Nature
  • 03/15 Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7 | Nature
  • 03/15 Common pitfalls and recommendations for using machine learning to detect and prognosticate for COVID-19 using chest radiographs and CT scans | Nature Machine Intelligence
  • 03/16 Structural impact on SARS-CoV-2 spike protein by D614G substitution | Science
  • 03/16 SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms: Cell
  • 03/16 N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2: Cell
  • 03/16 Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein: Cell
  • 03/16 Spread of a Variant SARS-CoV-2 in Long-Term Care Facilities in England | NEJM
  • 03/16 Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant | NEJM
  • 03/16 Vaccinating the oldest against COVID-19 saves both the most lives and most years of life | PNAS
  • 03/16 SARS-CoV-2 infection and transmission in primary schools in England in June–December, 2020 (sKIDs): an active, prospective surveillance study - The Lancet Child & Adolescent Health
  • 03/16 Arthritis after SARS-CoV-2 infection - The Lancet Rheumatology
  • 03/17 SARS-CoV-2 Epidemiology on a Public University Campus in Washington State | medRxiv
  • 03/17 An integrated analysis of contact tracing and genomics to assess the efficacy of travel restrictions on SARS-CoV-2 introduction and transmission in England from June to September, 2020 | medRxiv
  • 03/17 Associations of the BNT162b2 COVID-19 vaccine effectiveness with patient age and comorbidities | medRxiv
  • 03/17 Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19 | Modern Pathology
  • 03/17 Shifting attention to accuracy can reduce misinformation online | Nature
  • 03/17 Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant | NEJM
  • 03/17 Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study - The Lancet
  • 03/18 Myocarditis in naturally infected pets with the British variant of COVID-19 | bioRxiv
  • 03/18 Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England | The BMJ
  • 03/18 Antivirals with common targets against highly pathogenic viruses: Cell
  • 03/18 Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February - Eurosurveillance
  • 03/18 Early Release - Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 during Border Quarantine and Air Travel, New Zealand (Aotearoa) - Volume 27, Number 5—May 2021 - Emerging Infectious Diseases journal - CDC
  • 03/19 Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination | Infectious Diseases | JAMA | JAMA Network
  • 03/19 Combining initial chest CT with clinical variables in differentiating coronavirus disease 2019 (COVID-19) pneumonia from influenza pneumonia | Scientific Reports
  • 03/20 Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19 - PubMed
  • 03/20 Infection and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant: Cell Host & Microbe
  • 03/20 SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies: Cell
  • 03/20 Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study - The Lancet
  • 03/22 Association of Age With SARS-CoV-2 Antibody Response | Adolescent Medicine | JAMA Network Open | JAMA Network
  • 03/22 COVID-19 Survivors’ Reports of the Timing, Duration, and Health Impacts of Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection | medRxiv
  • 03/23 Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation | eLife
  • 03/23 Trends in Health Care Worker Intentions to Receive a COVID-19 Vaccine and Reasons for Hesitancy | Health Care Workforce | JAMA Network Open | JAMA Network
  • 03/23 Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers” - Graham - - Annals of Clinical and Translational Neurology - Wiley Online Library
  • 03/23 The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia | Science
  • 03/23 Emergence of the E484K Mutation in SARS-CoV-2 Lineage B.1.1.220 in Upstate New York | medRxiv
  • 03/23 Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. | medRxiv
  • 03/23 SARS-CoV-2 Infection after Vaccination in Health Care Workers in California | NEJM
  • 03/23 BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers | NEJM
  • 03/23 Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine | NEJM
  • 03/23 Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center | NEJM
  • 03/23 Higher airborne pollen concentrations correlated with increased SARS-CoV-2 infection rates, as evidenced from 31 countries across the globe | PNAS
  • 03/23 Using artificial intelligence to improve COVID-19 rapid diagnostic test result interpretation | PNAS
  • 03/23 Impacts of introducing and lifting nonpharmaceutical interventions on COVID-19 daily growth rate and compliance in the United States | PNAS
  • 03/23 Rapid identification and tracking of SARS-CoV-2 variants of concern - The Lancet
  • 03/23 Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study - The Lancet Microbe
  • 03/24 B.1.526 SARS-CoV-2 variants identified in New York City are neutralized by vaccine-elicited and therapeutic monoclonal antibodies | bioRxiv
  • 03/24 Quadrivalent influenza nanoparticle vaccines induce broad protection | Nature
  • 03/24 New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications | NEJM
  • 03/24 Serologic Screening of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Cats and Dogs during First Coronavirus Disease Wave, the Netherlands - Volume 27, Number 5—May 2021 - Emerging Infectious Diseases journal - CDC
  • 03/25 Emergence of porcine delta-coronavirus pathogenic infections among children in Haiti through independent zoonoses and convergent evolution | medRxiv
  • 03/25 Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England | Nature
  • 03/25 SARS-CoV-2 infection of the oral cavity and saliva | Nature Medicine
  • 03/25 Performance and operational feasibility of antigen and antibody rapid diagnostic tests for COVID-19 in symptomatic and asymptomatic patients in Cameroon: a clinical, prospective, diagnostic accuracy study - The Lancet Infectious Diseases
  • 03/26 Case Study: Longitudinal immune profiling of a SARS-CoV-2 reinfection in a solid organ transplant recipient | medRxiv
  • 03/26 Dramatic drop of new SARS-CoV-2 infections among health care workers after the first dose of the BNT162b2 mRNA Covid-19 Vaccine | medRxiv
  • 03/26 First manifestation of adult-onset Still's disease after COVID-19 - The Lancet Rheumatology
  • 03/28 Emergence of a SARS-CoV-2 E484K variant of interest in Arizona | medRxiv
  • 03/29 SARS-CoV2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential: Biophysical Journal
  • 03/29 Clinical performance evaluation of SARS-CoV-2 rapid antigen testing in point of care usage in comparison to RT-qPCR | medRxiv
  • 03/29 Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma | Nature
  • 03/29 The spatial landscape of lung pathology during COVID-19 progression | Nature
  • 03/29 Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine | Nature Medicine
  • 03/29 Early Release - Epidemiologic Evidence for Airborne Transmission of SARS-CoV-2 during Church Singing, Australia, 2020 - Volume 27, Number 6—June 2021 - Emerging Infectious Diseases journal - CDC
  • 03/30 Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States: Cell
  • 03/30 Antibody evasion by the P.1 strain of SARS-CoV-2: Cell
  • 03/30 mRNA vaccines take on immune tolerance | Nature Biotechnology
  • 03/30 Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial - The Lancet
  • 03/30 Pandemic moves and countermoves: vaccines and viral variants - The Lancet
  • 03/31 Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study | The BMJ
  • 03/31 Alterations in T and B cell function persist in convalescent COVID-19 patients: Med - Cell

    April 2021

  • 04/01 Quantitative Microbial Risk Assessment for Airborne Transmission of SARS-CoV-2 via Breathing, Speaking, Singing, Coughing, and Sneezing | Environmental Health Perspectives | Vol. 129, No. 4
  • 04/01 Computational epitope map of SARS-CoV-2 spike protein - PLOS
  • 04/01 Systems serology detects functionally distinct coronavirus antibody features in children and elderly | Nature Communications - Nature
  • 04/01 Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2 | Nature Medicine
  • 04/01 Early Release - Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil - Volume 27, Number 5—May 2021 - Emerging Infectious Diseases journal - CDC
  • 04/02 X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease | Science
  • 04/02 Qualitatively distinct modes of Sputnik V vaccine-neutralization escape by SARS-CoV-2 Spike variants | medRxiv
  • 04/03 Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States - ScienceDirect
  • 04/05 Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses: Immunity
  • 04/05 SARS-CoV-2 infectivity by viral load, S gene variants and demographic factors and the utility of lateral flow devices to prevent transmission | medRxiv
  • 04/06 Trends in Geographic and Temporal Distribution of US Children With Multisystem Inflammatory Syndrome During the COVID-19 Pandemic | Pediatrics | JAMA Pediatrics | JAMA Network
  • 04/06 Administration of a Second Dose of the Moderna COVID-19 Vaccine After an Immediate Hypersensitivity Reaction With the First Dose: Two Case Reports | Annals of Internal Medicine
  • 04/06 Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19 | Nature Reviews Immunology
  • 04/06 Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization | NEJM
  • 04/06 Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19 | NEJM
  • 04/06 Overdispersion in COVID-19 increases the effectiveness of limiting nonrepetitive contacts for transmission control | PNAS
  • 04/06 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records - The Lancet Psychiatry
  • 04/07 Reactive Infectious Mucocutaneous Eruption Associated With SARS-CoV-2 Infection | Dermatology | JAMA Dermatology | JAMA Network
  • 04/07 Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: A test-negative case-control study | medRxiv
  • 04/07 Drugs that inhibit TMEM16 proteins block SARS-CoV-2 Spike-induced syncytia | Nature
  • 04/07 Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351 | NEJM
  • 04/07 Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351) | NEJM
  • 04/07 SARS-CoV-2 spike E484K mutation reduces antibody neutralisation - ScienceDirect
  • 04/07 Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study - The Lancet Microbe
  • 04/08 Early T cell and binding antibody responses are associated with Covid-19 RNA vaccine efficacy onset: Med
  • 04/09 Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals | medRxiv
  • 04/09 Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination | NEJM
  • 04/09 Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination | NEJM
  • 04/09 SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) - ScienceDirect
  • 04/09 Correlates of protection from SARS-CoV-2 infection - The Lancet
  • 04/09 Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial - The Lancet Respiratory Medicine
  • 04/12 Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV | Nature
  • 04/12 Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study - The Lancet Infectious Diseases
  • 04/12 Lack of detail in population-level data impedes analysis of SARS-CoV-2 variants of concern and clinical outcomes - The Lancet Infectious Diseases
  • 04/12 Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study - The Lancet Public Health
  • 04/12 Epidemiology of Confirmed COVID-19 Deaths in Adults, England, March–December 2020 - Volume 27, Number 5—May 2021 - Emerging Infectious Diseases journal - CDC
  • 04/13 T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously SARS-CoV-2-Infected and Infection-Naive UK Healthcare Workers: A Multicentre, Prospective, Observational Cohort Study by Adrienn Angyal, Stephanie Longet, Shona Moore, Rebecca P. P
  • 04/13 Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children: Immunity
  • 04/13 Is IL-6 a key cytokine target for therapy in COVID-19? | Nature Reviews Immunology
  • 04/13 Ranking the risk of animal-to-human spillover for newly discovered viruses | PNAS
  • 04/13 Serum sample neutralisation of BBIBP-CorV and ZF2001 vaccines to SARS-CoV-2 501Y.V2 - The Lancet Microbe
  • 04/13 Suicide trends in the early months of the COVID-19 pandemic: an interrupted time-series analysis of preliminary data from 21 countries - The Lancet Psychiatry
  • 04/13 Introduction of ORF3a-Q57H SARS-CoV-2 Variant Causing Fourth Epidemic Wave of COVID-19, Hong Kong, China - Volume 27, Number 5—May 2021 - Emerging Infectious Diseases journal - CDC
  • 04/14 Spatiotemporal pattern of COVID-19 spread in Brazil | Science
  • 04/14 Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil | Science
  • 04/14 SARS-CoV-2 Antibody Response in Persons with Past Natural Infection | NEJM
  • 04/14 Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination | NEJM
  • 04/14 Pulmonary embolism and thrombocytopenia following ChAdOx1 vaccination - The Lancet
  • 04/14 Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination - The Lancet
  • 04/14 Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi Arabia - Volume 27, Number 5—May 2021 - Emerging Infectious Diseases journal - CDC
  • 04/15 COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital | Brain | Oxford Academic
  • 04/15 Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination | Science Immunology
  • 04/15 A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection: Cell Host & Microbe
  • 04/15 SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study - The Lancet Respiratory Medicine
  • 04/16 The SARS-CoV-2 Spike variant D614G favors an open conformational state | Science Advances
  • 04/16 # AstraZeneca vaccine disinformation on Twitter | medRxiv
  • 04/16 Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination — Response from the Manufacturer | NEJM
  • 04/16 SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia | NEJM
  • 04/16 Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination | NEJM
  • 04/17 BNT162b2 Vaccination Effectively Prevents the Rapid Rise of SARS-CoV-2 Variant B.1.1.7 in high risk populations in Israel: Cell Reports Medicine
  • 04/19 A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given i
  • 04/19 A systematic review and meta-analysis of psychological interventions to improve mental wellbeing | Nature Human Behaviour
  • 04/19 Statistical mechanics meets single-cell biology | Nature Reviews Genetics
  • 04/19 COVID-19 dynamics after a national immunization program in Israel | Nature Medicine
  • 04/19 Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma - The Lancet Haematology
  • 04/20 How accurately can we assess zoonotic risk? - PLOS
  • 04/20 SARS-CoV-2 Reinfection in a Liver Transplant Recipient | Annals of Internal Medicine
  • 04/20 Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.: Cell Reports Medicine
  • 04/20 Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant: Cell
  • 04/20 Single-cell multi-omics analysis of the immune response in COVID-19 | Nature Medicine
  • 04/20 Suicide in England in the COVID-19 pandemic: Early observational data from real time surveillance - The Lancet Regional Health – Europe
  • 04/21 Delayed Large Local Reactions to mRNA Vaccines | NEJM
  • 04/21 Vaccine Breakthrough Infections with SARS-CoV-2 Variants | NEJM
  • 04/22 SARS-CoV-2 can recruit a haem metabolite to evade antibody immunity | Science Advances
  • 04/22 Detection of SARS‐CoV‐2 in respiratory samples from cats in the UK associated with human‐to‐cat transmission - Hosie - 2021 - Veterinary Record - Wiley Online Library
  • 04/22 SARS-CoV-2 Transmission Risk Among National Basketball Association Players, Staff, and Vendors Exposed to Individuals With Positive Test Results After COVID-19 Recovery During the 2020 Regular and Postseason | Infectious Diseases | JAMA Internal Medicine
  • 04/22 Acute Ischemic Stroke During the Convalescent Phase of Asymptomatic COVID-2019 Infection in Men | Cerebrovascular Disease | JAMA Network Open | JAMA Network
  • 04/22 Rapid induction of antigen-specific CD4+ T cells guides coordinated humoral and cellular immune responses to SARS-CoV-2 mRNA vaccination | bioRxiv
  • 04/22 High-dimensional characterization of post-acute sequalae of COVID-19 | Nature
  • 04/23 Resurgence of SARS-CoV-2: detection by community viral surveillance | Science
  • 04/23 Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees | bioRxiv
  • 04/23 B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV: Cell
  • 04/23 Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study - The Lancet
  • 04/23 Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study - The Lancet
  • 04/23 Hospital admissions due to COVID-19 in Scotland after one dose of vaccine - The Lancet
  • 04/23 COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study - The Lancet
  • 04/24 Protection of previous SARS-CoV-2 infection is similar to that of BNT162b2 vaccine protection: A three-month nationwide experience from Israel | medRxiv
  • 04/26 The SARS-CoV-2 RNA interactome: Molecular Cell
  • 04/27 Interrupting vaccination policies can greatly spread SARS-CoV-2 and enhance mortality from COVID-19 disease: The AstraZeneca case for France and Italy: Chaos: An Interdisciplinary Journal of Nonlinear Science: Vol 31, No 4
  • 04/27 Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile | Science
  • 04/27 Performance Evaluation of Serial SARS-CoV-2 Rapid Antigen Testing During a Nursing Home Outbreak | Annals of Internal Medicine
  • 04/27 Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms: Cell Reports Medicine
  • 04/27 Single‐cell analyses reveal SARS‐CoV‐2 interference with intrinsic immune response in the human gut | Molecular Systems Biology
  • 04/27 A guideline to limit indoor airborne transmission of COVID-19 | PNAS
  • 04/27 COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year - The Lancet Haematology
  • 04/27 Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study - The Lancet Infectious Diseases
  • 04/27 Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study - The Lancet Oncology
  • 04/28 Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: Analysis of multiple factors - International Journal of Infectious Diseases
  • 04/28 Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study - The Lancet Diabetes & Endocrinology
  • 04/29 Complications of COVID-19 Nasopharyngeal Swab Test | Coronavirus (COVID-19) | JAMA Otolaryngology–Head & Neck Surgery | JAMA Network
  • 04/29 Household COVID-19 risk and in-person schooling | Science
  • 04/29 Previously infected vaccinees broadly neutralize SARS-CoV-2 variants | medRxiv
  • 04/29 A molecular single-cell lung atlas of lethal COVID-19 | Nature
  • 04/29 COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets | Nature
  • 04/30 US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021 | Coagulation Disorders | JAMA | JAMA Network
  • 04/30 COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program - Kentucky, March 2021 - PubMed
  • 04/30 Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose | Science
  • 04/30 Estimating the early impact of immunization against COVID-19 on deaths among elderly people in Brazil: analyses of secondary data on vaccine coverage and mortality | medRxiv

    May 2021

  • 05/01 Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet
  • 05/03 Viral genomes reveal patterns of the SARS-CoV-2 outbreak in Washington State | Science Translational Medicine
  • 05/03 COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters | Science Translational Medicine
  • 05/03 A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics | Nature Biomedical Engineering
  • 05/04 evolutionary portrait of the progenitor SARS-CoV-2 and its dominant offshoots in COVID-19 pandemic | Molecular Biology and Evolution | Oxford Academic
  • 05/04 Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes | Science
  • 05/04 Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to eight months post-symptom onset: Cell Reports Medicine
  • 05/04 Testing at scale during the COVID-19 pandemic | Nature Reviews Genetics
  • 05/04 SARS-CoV-2 related Paediatric Acute-onset Neuropsychiatric Syndrome - The Lancet Child & Adolescent Health
  • 05/05 SARS CoV-2 variant B.1.617.1 is highly pathogenic in hamsters than B.1 variant | bioRxiv
  • 05/05 Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study | The BMJ
  • 05/05 Delayed production of neutralizing antibodies correlates with fatal COVID-19 | Nature Medicine
  • 05/05 Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants | NEJM
  • 05/05 Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant | NEJM
  • 05/05 Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data - The Lancet
  • 05/06 Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers | Health Care Workforce | JAMA | JAMA Network
  • 05/06 Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce | Infectious Diseases | JAMA | JAMA Network
  • 05/06 Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets: Immunity
  • 05/06 Aerosol generating procedures: are they of relevance for transmission of SARS-CoV-2? - The Lancet Respiratory Medicine
  • 05/06 The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity - The Lancet Respiratory Medicine
  • 05/07 Rapid antigen testing in COVID-19 responses | Science
  • 05/07 Vaccination boosts naturally enhanced neutralizing breadth to SARS-CoV-2 one year after infection | bioRxiv
  • 05/07 Detection of persistent SARS-CoV-2 IgG antibodies in oral mucosal fluid and upper respiratory tract specimens following COVID-19 mRNA vaccination | medRxiv
  • 05/07 TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines | Nature Immunology
  • 05/07 Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study - The Lancet Rheumatology
  • 05/08 Association Between Myocarditis and Mortality in SARS-CoV-2 Patients in a Large Registry by Frank Annie, Haytham Alkhaimy, Aravinda Nanjundappa, Ahmad Elashery :: SSRN
  • 05/08 Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers - ScienceDirect
  • 05/10 Real-World Effectiveness of Ad26.COV2.S Adenoviral Vector Vaccine for COVID-19 by Juan Corchado-Garcia, David Puyraimond-Zemmour‬, Travis Hughes, Tudor Cristea-Platon, Patrick Lenehan, Colin Pawlowski, Sairam Bade, John C. O'Horo, Gregory J. Gores, Amy W.
  • 05/10 A global database of COVID-19 vaccinations | Nature Human Behaviour
  • 05/10 Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses | Nature
  • 05/11 Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium | Neurology | JAMA Network Open | JAMA Network
  • 05/11 Towards psychological herd immunity: Cross-cultural evidence for two prebunking interventions against COVID-19 misinformation - Melisa Basol, Jon Roozenbeek, Manon Berriche, Fatih Uenal, William P. McClanahan, Sander van der Linden, 2021
  • 05/11 Catch me if you can: Superspreading of SARS-CoV-2: Trends in Microbiology
  • 05/11 JCI - A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19 - JCI
  • 05/11 Cerebral venous thrombosis and portal vein thrombosis: a retrospective cohort study of 537,913 COVID-19 cases | medRxiv
  • 05/11 SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes | Nature Communications
  • 05/11 Reversed-engineered human alveolar lung-on-a-chip model | PNAS
  • 05/11 Automated, multiparametric monitoring of respiratory biomarkers and vital signs in clinical and home settings for COVID-19 patients | PNAS
  • 05/11 Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK - The Lancet Diabetes & Endocrinology
  • 05/12 Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series | Dermatology | JAMA Dermatology | JAMA Network
  • 05/12 mRNA vaccine-induced SARS-CoV-2-specific T cells recognize B.1.1.7 and B.1.351 variants but differ in longevity and homing properties depending on prior infection status | bioRxiv
  • 05/12 The epidemiological impact of the NHS COVID-19 App | Nature
  • 05/12 Structural basis for broad coronavirus neutralization | Nature Structural & Molecular Biology
  • 05/12 BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants | NEJM
  • 05/12 A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine - ScienceDirect
  • 05/12 Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial – Authors' reply - The Lancet
  • 05/12 Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial - The Lancet
  • 05/12 Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data - The Lancet
  • 05/13 Infections, Hospitalizations, and Deaths Averted Via Direct Effects of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine in a Nationwide Vaccination Campaign, Israel by Eric J. Haas, John M. McLaughlin, Farid Khan, Frederick J. Angulo, Emilia Anis, Marc
  • 05/13 Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome | Science
  • 05/14 Archival influenza virus genomes from Europe reveal genomic and phenotypic variability during the 1918 pandemic | bioRxiv
  • 05/14 Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19: Cell Host & Microbe
  • 05/14 Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial - The Lancet
  • 05/15 Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM
  • 05/16 Identification of SARS-CoV-2 P.1-related lineages in Brazil provides new insights about the mechanisms of emergence of Variants of Concern - nCoV-2019 Genomic Epidemiology - Virological
  • 05/16 Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants | bioRxiv
  • 05/16 The Spike Proteins of SARS-CoV-2 B.1.617 and B.1.618 Variants Identified in India Provide Partial Resistance to Vaccine-elicited and Therapeutic Monoclonal Antibodies | bioRxiv
  • 05/16 Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease.: Immunity
  • 05/17 High Seroprevalence of SARS-CoV-2 Eight Months After Introduction in Nairobi, Kenya by Isaac A. Ngere, Jeanette Dawa, Elizabeth Hunsperger, Nancy Otieno, Moses Masika, Patrick Amoth, Lyndah Makayotto, Carolyne Nasimiyu, Bronwyn Mei Gunn, Bryan Nyawanda, O
  • 05/17 Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection | Nature Medicine
  • 05/17 Genome-wide bioinformatic analyses predict key host and viral factors in SARS-CoV-2 pathogenesis | Communications Biology
  • 05/18 Fast SARS-CoV-2 virus detection using disposable cartridge strips and a semiconductor-based biosensor platform: Journal of Vacuum Science & Technology B: Vol 39, No 3
  • 05/18 Seropositivity in blood donors and pregnant women during the first year of SARS‐CoV‐2 transmission in Stockholm, Sweden - Castro Dopico - - Journal of Internal Medicine - Wiley Online Library
  • 05/18 Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2 | Science
  • 05/18 SARS-CoV-2 infects human pancreatic β-cells and elicits β-cell impairment: Cell Metabolism
  • 05/18 SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition: Cell Reports Medicine
  • 05/19 Characteristics Associated With Multisystem Inflammatory Syndrome Among Adults With SARS-CoV-2 Infection | Infectious Diseases | JAMA Network Open | JAMA Network
  • 05/19 Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study | The BMJ
  • 05/19 Diverse Functional Autoantibodies in Patients with COVID-19 | Nature
  • 05/19 Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents | NEJM
  • 05/19 SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity - The Lancet Infectious Diseases
  • 05/20 Novel Canine Coronavirus Isolated from a Hospitalized Pneumonia Patient, East Malaysia | Clinical Infectious Diseases | Oxford Academic
  • 05/20 Preliminary Analysis of Association Between COVID-19 Vaccination and Sudden Hearing Loss Using US Centers for Disease Control and Prevention Vaccine Adverse Events Reporting System Data | Vaccination | JAMA Otolaryngology–Head & Neck Surgery | JAMA Networ
  • 05/20 Dispersal dynamics of SARS-CoV-2 lineages during the first epidemic wave in New York City - PLOS
  • 05/20 Face masks effectively limit the probability of SARS-CoV-2 transmission | Science
  • 05/20 Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants | Science
  • 05/21 Nonreplicable publications are cited more than replicable ones | Science Advances
  • 05/21 SARS-CoV-2 Human T cell Epitopes: adaptive immune response against COVID-19.: Cell Host & Microbe
  • 05/21 SARS-CoV-2 infection of BNT162b2(mRNA)-vaccinated individuals is not restricted to variants of concern or high-risk exposure environments | medRxiv
  • 05/21 Single-dose SARS-CoV-2 vaccine in a prospective cohort of COVID-19 patients | medRxiv
  • 05/22 Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study - The Lancet
  • 05/24 Public Trust and Willingness to Vaccinate Against COVID-19 in the US From October 14, 2020, to March 29, 2021 | Infectious Diseases | JAMA | JAMA Network
  • 05/24 An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies: Cell
  • 05/24 Effectiveness of COVID-19 vaccines against the B.1.617.2 variant | medRxiv
  • 05/24 Rapid single-molecule detection of COVID-19 and MERS antigens via nanobody-functionalized organic electrochemical transistors | Nature Biomedical Engineering
  • 05/24 SARS-CoV-2 simulations go exascale to predict dramatic spike opening and cryptic pockets across the proteome | Nature Chemistry
  • 05/24 SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans | Nature
  • 05/24 6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study - The Lancet Child & Adolescent Health
  • 05/25 Complement control for COVID-19 | Science Immunology
  • 05/25 SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees | Science Immunology
  • 05/25 Association Between Bitter Taste Receptor Phenotype and Clinical Outcomes Among Patients With COVID-19 | Infectious Diseases | JAMA Network Open | JAMA Network
  • 05/25 Estimating infectiousness throughout SARS-CoV-2 infection course | Science
  • 05/25 Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series | Annals of Internal Medicine
  • 05/25 Symptoms After COVID-19 Vaccination in Patients With Persistent Symptoms After Acute Infection: A Case Series | Annals of Internal Medicine
  • 05/25 Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State | medRxiv
  • 05/25 Impacts of social distancing policies on mobility and COVID-19 case growth in the US | Nature Communications
  • 05/25 Immune response to SARS-CoV-2 variants of concern in vaccinated individuals | Nature Communications
  • 05/25 COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence | Nature Medicine
  • 05/25 Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection | Nature Metabolism
  • 05/25 Just 2% of SARS-CoV-2−positive individuals carry 90% of the virus circulating in communities | PNAS
  • 05/25 Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues | PNAS
  • 05/26 Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses | Science Advances
  • 05/26 Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review | Infectious Diseases | JAMA Network Open | JAMA Network
  • 05/26 Mask Use in Community Settings in the Context of COVID-19: A Systematic Review of Ecological Data by Nathan Ford, Haley K. Holmer, Roger Chou, Paul Villeneuve, April Baller, Maria Van Kerkhove, Benedetta Allegranzi :: SSRN
  • 05/26 Social media use in China before and during COVID-19: Preliminary results from an online retrospective survey - PubMed
  • 05/26 Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals | bioRxiv
  • 05/26 Emergence of a new SARS-CoV-2 variant from GR clade with a novel S glycoprotein mutation V1230L in West Bengal, India | medRxiv
  • 05/26 Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2 | Nature Medicine
  • 05/26 “Vaccine-Induced Covid-19 Mimicry” Syndrome:Splice reactions within the SARS-CoV-2 Spike open reading frame result in Spike protein variants that may cause thromboembolic events in patients immunized with vector-based vaccines | Research Square
  • 05/27 Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection: Results From the Big Ten COVID-19 Cardiac Registry | Cardiology | JAMA Cardiology | JAMA Network
  • 05/27 Broad auto-reactive IgM responses are common in critically ill patients, including those with COVID-19: Cell Reports Medicine
  • 05/27 BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans | Nature
  • 05/27 SARS-CoV-2 variants of concern are emerging in India | Nature Medicine
  • 05/27 Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents | NEJM
  • 05/27 Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial - The Lancet Infectious Diseases
  • 05/27 Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac - The Lancet Infectious Diseases
  • 05/28 Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy | Infectious Diseases | JAMA Internal Medicine | JAMA Network
  • 05/28 Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer | Oncology | JAMA Oncology | JAMA Network
  • 05/29 Inferring SARS-CoV-2 variant within-host kinetics | medRxiv
  • 05/29 The indirect effect of mRNA-based Covid-19 vaccination on unvaccinated household members | medRxiv
  • 05/29 Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection | Nature Reviews Immunology
  • 05/30 Small Airways Disease is a Post-Acute Sequelae of SARS-CoV-2 Infection | medRxiv
  • 05/31 After COVID-19 successes, researchers push to develop mRNA vaccines for other diseases | Nature Medicine
  • 05/31 AI for radiographic COVID-19 detection selects shortcuts over signal | Nature Machine Intelligence

    June 2021

  • 06/01 Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study - PLOS
  • 06/01 Symptomatic Acute Myocarditis in Seven Adolescents Following Pfizer-BioNTech COVID-19 Vaccination | American Academy of Pediatrics
  • 06/01 SARS-CoV-2 cell-to-cell spread occurs rapidly and is insensitive to antibody neutralization | bioRxiv
  • 06/01 SARS-CoV-2 variants, spike mutations and immune escape | Nature Reviews Microbiology
  • 06/02 Proof of concept for real-time detection of SARS CoV-2 infection with an electronic nose - PLOS
  • 06/02 A global analysis of the impact of COVID-19 stay-at-home restrictions on crime | Nature Human Behaviour
  • 06/02 Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study | NEJM
  • 06/02 Can the USA return to pre-COVID-19 normal by July 4? - The Lancet Infectious Diseases
  • 06/03 Estimating epidemiologic dynamics from cross-sectional viral load distributions | Science
  • 06/03 Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants | Nature
  • 06/03 Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination - The Lancet
  • 06/04 A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T-cell responses: Cell Host & Microbe
  • 06/05 Neutralization against B.1.351 and B.1.617.2 with sera of COVID-19 recovered cases and vaccinees of BBV152 | bioRxiv
  • 06/05 The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies: Cell
  • 06/06 Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant | bioRxiv
  • 06/07 Dynamics of the SARS-CoV-2 antibody response up to 10 months after infection | Cellular & Molecular Immunology
  • 06/07 SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care | Nature Communications
  • 06/07 Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 | Nature
  • 06/08 Senolytics reduce coronavirus-related mortality in old mice | Science
  • 06/08 SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD and S2: Cell
  • 06/08 Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species: Immunity
  • 06/08 Structural basis for SARS-CoV-2 envelope protein recognition of human cell junction protein PALS1 | Nature Communications
  • 06/08 Collectivism predicts mask use during COVID-19 | PNAS
  • 06/08 Analyzing the vast coronavirus literature with CoronaCentral | PNAS
  • 06/08 Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis - The Lancet Rheumatology
  • 06/09 Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar | Global Health | JAMA | JAMA Network
  • 06/09 SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse | Nature Microbiology
  • 06/09 Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans | Nature
  • 06/09 First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland | Nature Medicine
  • 06/09 Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom | Nature Medicine
  • 06/09 Delayed Large Local Reactions to mRNA Covid-19 Vaccines in Blacks, Indigenous Persons, and People of Color | NEJM
  • 06/09 Adjunct Immune Globulin for Vaccine-Induced Thrombotic Thrombocytopenia | NEJM
  • 06/10 BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants | Nature
  • 06/10 Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals | Nature Medicine
  • 06/11 Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4+ T cell help: Cell Reports
  • 06/11 Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum: Cell
  • 06/11 In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies: Cell
  • 06/11 Vaccination reduces need for emergency care in breakthrough COVID-19 infections: A multicenter cohort study | medRxiv
  • 06/14 Effectiveness of COVID-19 vaccines against hospital admission with the Delta (B.1.617.2) variant - Public library - PHE national - Knowledge Hub
  • 06/14 Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection | Nature
  • 06/14 Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals | Nature Medicine
  • 06/15 Serum neurofilament light protein correlates with unfavorable clinical outcomes in hospitalized patients with COVID-19 | Science Translational Medicine
  • 06/15 Predicted domination of variant Delta of SARS-CoV-2 before Tokyo Olympic games, Japan | medRxiv
  • 06/15 Divergent trajectories of antiviral memory after SARS-Cov-2 infection | Research Square
  • 06/16 Antibody and B cell responses to SARS-CoV-2 infection and vaccination: Cell Host & Microbe
  • 06/16 Reconstruction of a large-scale outbreak of SARS-CoV-2 infection in Iceland informs vaccination strategies | medRxiv
  • 06/16 Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial | medRxiv
  • 06/16 Immunotherapy for MIS-C — IVIG, Glucocorticoids, and Biologics | NEJM
  • 06/16 Treatment of Multisystem Inflammatory Syndrome in Children | NEJM
  • 06/17 Will we ever wash our hands of lubrication theory?: Physics of Fluids: Vol 33, No 8
  • 06/17 Sperm Parameters Before and After COVID-19 mRNA Vaccination | Urology | JAMA | JAMA Network
  • 06/17 SARS-CoV-2 spike P681R mutation enhances and accelerates viral fusion | bioRxiv
  • 06/17 Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19 | Nature Nanotechnology
  • 06/17 Causation or confounding: why controls are critical for characterizing long COVID | Nature Medicine
  • 06/17 Spike D614G — A Candidate Vaccine Antigen Against Covid-19 | NEJM
  • 06/18 Alarming COVID study indicates long-term loss of gray matter and other brain tissue - Medical News
  • 06/20 Rapid spread of the SARS-CoV-2 δ variant in the area of Paris (France) in June 2021 | medRxiv
  • 06/21 Assessing the Association Between Social Gatherings and COVID-19 Risk Using Birthdays | Public Health | JAMA Internal Medicine | JAMA Network
  • 06/21 In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains - PubMed
  • 06/22 Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients | Science Immunology
  • 06/22 COVID-19 vaccine side effects: The positives about feeling bad | Science Immunology
  • 06/22 Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice | Science
  • 06/22 The total number and mass of SARS-CoV-2 virions | PNAS
  • 06/22 SARS-CoV-2 B.1.617.2 Delta variant emergence and vaccine breakthrough | Research Square
  • 06/22 Remote home monitoring (virtual wards) for confirmed or suspected COVID-19 patients: a rapid systematic review - EClinicalMedicine
  • 06/22 Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study - The Lancet Infectious Diseases
  • 06/22 Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study - The Lancet Infectious Diseases
  • 06/22 SARS-CoV-2 variants and considerations of inferring causality on disease severity - The Lancet Infectious Diseases
  • 06/23 Primary, Recall, and Decay Kinetics of SARS-CoV-2 Vaccine Antibody Responses | ACS Nano
  • 06/23 Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity | Science
  • 06/23 Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | Science
  • 06/23 Increased lung cell entry of B.1.617.2 and evasion of antibodies induced by infection and BNT162b2 vaccination | bioRxiv
  • 06/23 Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques | Nature
  • 06/23 Long COVID in a prospective cohort of home-isolated patients | Nature Medicine
  • 06/23 Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients | Scientific Reports
  • 06/23 Effect of Vaccination on Household Transmission of SARS-CoV-2 in England | NEJM
  • 06/23 Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients | NEJM
  • 06/23 Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study - The Lancet Infectious Diseases
  • 06/23 Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study - The Lancet Infectious Diseases
  • 06/23 Invasive mould disease in fatal COVID-19: a systematic review of autopsies - The Lancet Microbe
  • 06/24 Clinical Outcomes for Patients With Anosmia 1 Year After COVID-19 Diagnosis | Infectious Diseases | JAMA Network Open | JAMA Network
  • 06/25 Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test | Science Advances
  • 06/25 Pfizer-BioNTech Vaccine Effectiveness Against SARS-CoV-2 Infection: Findings From a Large Observational Study in Israel by Yaki Saciuk, Jennifer Kertes, Micha Mandel, Beatriz Hemo, Naama Shamir Stein, Anat Ekka Zohar :: SSRN
  • 06/25 Hybrid immunity | Science
  • 06/25 Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial - The Lancet
  • 06/25 Heterologous vaccine regimens against COVID-19 - The Lancet
  • 06/28 Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination | medRxiv
  • 06/28 SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses | Nature
  • 06/28 Wearable materials with embedded synthetic biology sensors for biomolecule detection | Nature Biotechnology
  • 06/28 AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC - The Lancet
  • 06/28 Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial - The Lancet Infectious Diseases
  • 06/28 The SARS-CoV-2 B.1.1.7 variant and increased clinical severity—the jury is out - The Lancet Infectious Diseases
  • 06/28 COVID-19 vaccines for children younger than 12 years: are we ready? - The Lancet Infectious Diseases
  • 06/29 Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military | Cardiology | JAMA Cardiology | JAMA Network
  • 06/29 Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination | Cardiology | JAMA Cardiology | JAMA Network
  • 06/29 Thrombosis With Thrombocytopenia After the Messenger RNA–1273 Vaccine | Annals of Internal Medicine
  • 06/29 Thrombosis After Vaccination With Messenger RNA–1273: Is This Vaccine-Induced Thrombosis and Thrombocytopenia or Thrombosis With Thrombocytopenia Syndrome? | Annals of Internal Medicine
  • 06/29 Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses: Cell
  • 06/29 Lessons from a local effort to screen for SARS-CoV-2 | PNAS
  • 06/30 Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants | Science
  • 06/30 SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern | Science
  • 06/30 Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2 | Nature
  • 06/30 Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines | NEJM
  • 06/30 Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine | NEJM

    July 2021

  • 07/01 Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals: Cell Reports Medicine
  • 07/01 Cerebral Venous Thrombosis | NEJM
  • 07/02 Neutralization of Delta variant with sera of Covishield vaccinees and COVID-19 recovered vaccinated individuals | bioRxiv
  • 07/02 Temporal Maturation of Neutralizing Antibodies in COVID-19 Convalescent Individuals Improves Potency and Breadth to Circulating SARS-CoV-2 Variants: Immunity
  • 07/02 Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): a, double-blind, randomised, controlled phase 3 trial | medRxiv
  • 07/03 The Emergence of SARS-CoV-2 Variant Lambda (C.37) in South America | medRxiv
  • 07/03 Prominent Spatiotemporal Waves of COVID-19 Incidence in the United States: Implications for Causality, Forecasting, and Control | medRxiv
  • 07/05 Low dose mRNA-1273 COVID-19 vaccine generates durable T cell memory and antibodies enhanced by pre-existing crossreactive T cell memory | medRxiv
  • 07/05 Fractionation of COVID-19 vaccine doses could extend limited supplies and reduce mortality | Nature Medicine
  • 07/06 Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection | Open Forum Infectious Diseases | Oxford Academic
  • 07/06 Seroprevalence of and Risk Factors Associated With SARS-CoV-2 Infection in Health Care Workers During the Early COVID-19 Pandemic in Italy | Infectious Diseases | JAMA Network Open | JAMA Network
  • 07/06 Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting | Annals of Internal Medicine
  • 07/06 A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation: Cell
  • 07/07 Assessment of Prolonged Physiological and Behavioral Changes Associated With COVID-19 Infection | Infectious Diseases | JAMA Network Open | JAMA Network
  • 07/07 Long-Term Persistence of SARS-CoV-2 Neutralizing Antibody Responses After Infection and Estimates of the Duration of Protection by Eric H.Y. Lau, David S. C. Hui, Owen Tak-Yin Tsang, Wai-Hung Chan, Mike YE Kwan, Susan S. Chiu, Samuel MS Cheng, Ronald LW Ko, John KC Li, Sara Chaothai, Chi H. Tsang, Leo LM Poon, J.S. Malik Peiris :: SSRN
  • 07/07 Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States | Science Translational Medicine
  • 07/07 Viral infection and transmission in a large well-traced outbreak caused by the Delta SARS-CoV-2 variant - SARS-CoV-2 coronavirus / nCoV-2019 Genomic Epidemiology - Virological
  • 07/07 Progressive Increase in Virulence of Novel SARS-CoV-2 Variants in Ontario, Canada, from December to July, 2021 | medRxiv
  • 07/07 Antibody epitopes in vaccine-induced immune thrombotic thrombocytopenia | Nature
  • 07/07 Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants | NEJM
  • 07/07 Breakthrough SARS-CoV-2 Infections in Prison after Vaccination | NEJM
  • 07/07 Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia | NEJM
  • 07/07 Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile | NEJM
  • 07/07 The Origins of SARS-CoV-2: A Critical Review | Zenodo
  • 07/08 Corneal confocal microscopy identifies corneal nerve fibre loss and increased dendritic cells in patients with long COVID | British Journal of Ophthalmology
  • 07/08 SARS-CoV-2 targets MAVS for immune evasion | Nature Cell Biology
  • 07/08 Mapping the human genetic architecture of COVID-19 | Nature
  • 07/08 Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization | Nature
  • 07/08 After the pandemic: perspectives on the future trajectory of COVID-19 | Nature
  • 07/09 mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar | Nature Medicine
  • 07/10 SARS-COV-2 spike binding to ACE2 in living cells monitored by TR-FRET: Cell Chemical Biology
  • 07/12 Comparison of the Immunogenicity of BNT162b2 and CoronaVac COVID-19 Vaccines in Hong Kong: An Observational Cohort Study by Chris Ka Pun Mok, Carolyn A. Cohen, Samuel M.S. Cheng, Chunke Chen, Kin-On Kwok, Karen Yiu, Tat-On Chan, Maireid Bull, Kwun Cheung Ling, Zixi Dai, Susanna S. Ng, Grace C.Y. Lui, Chao Wu, Gaya K. Amarasinghe, Daisy W. Leung, Samuel Yeung Shan Wong, Sophie A. Valkenburg, J.S. Malik Peiris, David S. C. Hui :: SSRN
  • 07/12 Systems vaccinology of the BNT162b2 mRNA vaccine in humans | Nature
  • 07/13 Antibody response after second BNT162b2 dose in allogeneic HSCT recipients - The Lancet
  • 07/14 SnapShot: SARS-CoV-2 antibodies: Cell Host & Microbe
  • 07/14 SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape | Nature
  • 07/14 Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination | Nature Medicine
  • 07/14 Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination | NEJM
  • 07/14 Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination | NEJM
  • 07/14 Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19 | NEJM
  • 07/14 Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study - The Lancet Child & Adolescent Health
  • 07/15 Spike-antibody waning after second dose of BNT162b2 or ChAdOx1 - The Lancet
  • 07/15 Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19 - The Lancet Microbe
  • 07/17 Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study - The Lancet
  • 07/18 Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity in uninfected and previously infected individuals | medRxiv
  • 07/19 Comparison of Neutralizing Antibody Titers Elicited by mRNA and Adenoviral Vector Vaccine against SARS-CoV-2 Variants | bioRxiv
  • 07/19 Cardiomyocytes Recruit Monocytes upon SARS-CoV-2 Infection by Secreting CCL2: Stem Cell Reports
  • 07/19 SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo’ | Nature Communications
  • 07/19 Broad sarbecovirus neutralization by a human monoclonal antibody | Nature
  • 07/20 Post-Vaccination Symptomatic SARS-CoV-2 Infections are Minimal and Non-Serious: An Observational Multicenter Indian Cohort Study of 28342 Healthcare Workers by Raju Vaishya, Anupam Sibal, Arpita Malani, Sujoy Kar, Hari Prasad K., Kiran SV, Sangita Reddy,
  • 07/20 Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2 | Science
  • 07/20 SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting | Annals of Internal Medicine
  • 07/20 Screening for SARS-CoV-2 Antigen Before a Live Indoor Music Concert: An Observational Study | Annals of Internal Medicine
  • 07/20 Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells: Cell Reports Medicine
  • 07/20 Transparent communication about negative features of COVID-19 vaccines decreases acceptance but increases trust | PNAS
  • 07/20 Ongoing global and regional adaptive evolution of SARS-CoV-2 | PNAS
  • 07/21 Household Transmission of SARS-CoV-2 from Children and Adolescents | NEJM
  • 07/21 Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant | NEJM
  • 07/22 Longitudinal assessment of COVID-19 vaccine acceptance and uptake among frontline medical workers in Los Angeles, California | Clinical Infectious Diseases | Oxford Academic
  • 07/22 Optimizing testing for COVID-19 in India - PLOS
  • 07/22 Safety and Cross-Variant Immunogenicity of a Three-Dose COVID-19 mRNA Vaccine Regimen in Kidney Transplant Recipients by Filippo Massa, Marion Cremoni, Alexandre Gerard, Hanen Grabsi, Lory Rogier, Mathilde Blois, Nadia Ben Hassen, Matthieu Rouleau, Susana
  • 07/22 The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies - PubMed
  • 07/22 Delta variants of SARS-CoV-2 cause significantly increased vaccine breakthrough COVID-19 cases in Houston, Texas | medRxiv
  • 07/22 Covid-19 Vaccine Acceptance in California State Prisons | NEJM
  • 07/22 Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines | NEJM
  • 07/22 Evidence for antibody as a protective correlate for COVID-19 vaccines - ScienceDirect
  • 07/23 Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses | Nephrology | JAMA | JAMA Network
  • 07/26 Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose | Vaccination | JAMA Internal Medicine | JAMA Network
  • 07/26 Long covid—mechanisms, risk factors, and management | The BMJ
  • 07/26 Emergence of an early SARS-CoV-2 epidemic in the United States: Cell
  • 07/26 Protection afforded by the BNT162b2 and mRNA-1273 COVID-19 vaccines in fully vaccinated cohorts with and without prior infection | medRxiv
  • 07/26 Mucosal vaccines — fortifying the frontiers | Nature Reviews Immunology
  • 07/26 A ‘mix and match’ approach to SARS-CoV-2 vaccination | Nature Medicine
  • 07/26 Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination | Nature Medicine
  • 07/26 Comparative analysis of ChAdOx1 nCoV-19 and Ad26.COV2.S SARS-CoV-2 vector vaccines | Research Square
  • 07/27 Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques | mBio
  • 07/27 Minute-scale detection of SARS-CoV-2 using a low-cost biosensor composed of pencil graphite electrodes | PNAS
  • 07/27 Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis - The Lancet
  • 07/28 Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant dependent manner | medRxiv
  • 07/28 Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine | medRxiv
  • 07/28 Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine | medRxiv
  • 07/28 Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine | Nature
  • 07/29 Presumed SARS-CoV-2 Viral Particles in the Human Retina of Patients With COVID-19 | Ophthalmology | JAMA Ophthalmology | JAMA Network
  • 07/29 Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates | Science
  • 07/29 SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection | Nature Communications
  • 07/29 Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study - The Lancet
  • 07/30 Post-viral effects of COVID-19 in the olfactory system and their implications - The Lancet Neurology
  • 07/30 The mechanisms of smell loss after SARS-CoV-2 infection - The Lancet Neurology
  • 07/31 Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study | medRxiv

    August 2021

  • 08/02 Accelerated COVID-19 vaccine development: milestones, lessons, and prospects: Immunity
  • 08/02 Studying SARS-CoV-2 infectivity and therapeutic responses with complex organoids | Nature Cell Biology
  • 08/02 Behavioral Nudges Increase COVID-19 Vaccinations | Nature
  • 08/02 Understanding why superspreading drives the COVID-19 pandemic but not the H1N1 pandemic - The Lancet Infectious Diseases
  • 08/03 Broad betacoronavirus neutralization by a stem helix–specific human antibody | Science
  • 08/03 Estimating SARS-CoV-2 infections from deaths, confirmed cases, tests, and random surveys | PNAS
  • 08/03 Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2 - The Lancet Child & Adolescent Health
  • 08/04 Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19 | NEJM
  • 08/05 Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort | medRxiv
  • 08/05 SARS-CoV-2 Variants in Patients with Immunosuppression | NEJM
  • 08/06 SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine | Infectious Diseases | JAMA Network Open | JAMA Network
  • 08/06 Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence | medRxiv
  • 08/06 Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses | Nature Communications
  • 08/07 The unique evolutionary dynamics of the SARS-CoV-2 Delta variant | medRxiv
  • 08/09 Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence | medRxiv
  • 08/09 Immunogenicity of BNT162b2 vaccine Against the Alpha and Delta Variants in Immunocompromised Patients | medRxiv
  • 08/10 Transmission of SARS-CoV-2 Delta Variant Among Vaccinated Healthcare Workers, Vietnam by Nguyen Van Vinh Chau, Nghiem My Ngoc, Lam Anh Nguyet, Vo Minh Quang, Nguyen Thi Han Ny, Dao Bach Khoa, Nguyen Thanh Phong, Le Mau Toan, Nguyen Thi Thu Hong, Nguyen Th - The Lancet
  • 08/10 Two doses of the SARS-CoV-2 BNT162b2 vaccine enhances antibody responses to variants in individuals with prior SARS-CoV-2 infection | Science Translational Medicine
  • 08/10 Full vaccination suppresses SARS-CoV-2 delta variant mutation frequency | medRxiv
  • 08/10 Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial | medRxiv
  • 08/10 Pairing facts with imagined consequences improves pandemic-related risk perception | PNAS
  • 08/10 Elite party cues increase vaccination intentions among Republicans | PNAS
  • 08/10 Empirical evidence to understand the human factor for effective rapid testing against SARS-CoV-2 | PNAS
  • 08/11 Molecular basis of immune evasion by the delta and kappa SARS-CoV-2 variants | bioRxiv
  • 08/11 Shedding of Infectious SARS-CoV-2 Despite Vaccination when the Delta Variant is Prevalent - Wisconsin, July 2021 | medRxiv
  • 08/11 BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the Delta (B.1.617.2) variant in Qatar | medRxiv
  • 08/11 Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients | NEJM
  • 08/11 Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents | NEJM
  • 08/12 Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants | Science
  • 08/12 Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immune responses to SARS-CoV-2 mRNA vaccination: Immunity
  • 08/12 Transmission dynamics and epidemiological characteristics of Delta variant infections in China | medRxiv
  • 08/12 Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave - The Lancet
  • 08/12 Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study - The Lancet Respiratory Medicine
  • 08/13 Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants | Science
  • 08/13 Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant | bioRxiv
  • 08/13 Protective heterologous T cell immunity in COVID-19 induced by the trivalent Measles-Mumps-Rubella and Tetanus-Diptheria-Pertussis vaccine antigens: Med
  • 08/13 Transmission dynamics and epidemiological characteristics of Delta variant infections in China | medRxiv
  • 08/13 Rapid genome sequencing in hospitals to identify potential vaccine-escape SARS-CoV-2 variants - The Lancet Infectious Diseases
  • 08/14 Delta variant and mRNA Covid-19 vaccines effectiveness: higher odds of vaccine infection breakthroughs | medRxiv
  • 08/16 Association of Vaccine Type and Prior SARS-CoV-2 Infection With Symptoms and Antibody Measurements Following Vaccination Among Health Care Workers | Infectious Diseases | JAMA Internal Medicine | JAMA Network
  • 08/16 Association of Age and Pediatric Household Transmission of SARS-CoV-2 Infection | Infectious Diseases | JAMA Pediatrics | JAMA Network
  • 08/16 Vaccine nationalism and the dynamics and control of SARS-CoV-2 | Science
  • 08/16 A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants: Immunity
  • 08/17 Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant | bioRxiv
  • 08/17 Live Imaging of SARS-CoV-2 Infection in Mice Reveals that Neutralizing Antibodies Require Fc Function for Optimal Efficacy: Immunity
  • 08/17 SARS-CoV-2 aerosol transmission in schools: the effectiveness of different interventions | medRxiv
  • 08/17 No evidence of human genome integration of SARS-CoV-2 found by long-read DNA sequencing - ScienceDirect
  • 08/17 SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination - The Lancet
  • 08/17 Early Release - Real-Time Genomics for Tracking Severe Acute Respiratory Syndrome Coronavirus 2 Border Incursions after Virus Elimination, New Zealand - Volume 27, Number 9—September 2021 - Emerging Infectious Diseases journal - CDC
  • 08/18 The Origins of SARS-CoV-2: A Critical Review: Cell
  • 08/18 A third COVID-19 vaccine shot markedly boosts neutralizing antibody potency and breadth | medRxiv
  • 08/18 Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children | Nature Biotechnology
  • 08/18 Early Convalescent Plasma for High-Risk Outpatients with Covid-19 | NEJM
  • 08/18 Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors | NEJM
  • 08/19 Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths | Science Immunology
  • 08/19 Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection | medRxiv
  • 08/19 A glycan gate controls opening of the SARS-CoV-2 spike protein | Nature Chemistry
  • 08/22 The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines | bioRxiv
  • 08/22 The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants: Cell Reports
  • 08/23 COVID-19 Transmission Dynamics Among Close Contacts of Index Patients With COVID-19: A Population-Based Cohort Study in Zhejiang Province, China | Global Health | JAMA Internal Medicine | JAMA Network
  • 08/23 Six-Month Effectiveness of BNT162B2 mRNA COVID-19 Vaccine in a Large US Integrated Health System: A Retrospective Cohort Study by Sara Y. Tartof, Jeff M. Slezak, Heidi Fischer, Vennis Hong, Bradley K. Ackerson, Omesh N. Ranasinghe, Timothy B. Frankland, O
  • 08/23 Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19 | Science Translational Medicine
  • 08/23 mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern | bioRxiv
  • 08/24 Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome | PNAS
  • 08/24 Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis | PNAS
  • 08/24 Morbidity and mortality from COVID-19 post-vaccination breakthrough infections in association with vaccines and the emergence of variants in Bahrain | Research Square
  • 08/25 Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections | medRxiv
  • 08/25 mRNA vaccines for infectious diseases: principles, delivery and clinical translation | Nature Reviews Drug Discovery
  • 08/26 The continuous evolution of SARS-CoV-2 in South Africa: a new lineage with rapid accumulation of mutations of concern and global detection | medRxiv
  • 08/26 Durability of antibody responses elicited by a single dose of Ad26.COV2.S and substantial increase following late boosting | medRxiv
  • 08/26 Long-term immunogenicity of BNT162b2 vaccination in the elderly and in younger health care workers | medRxiv
  • 08/26 Burden and characteristics of COVID-19 in the United States during 2020 | Nature
  • 08/26 CoronaVac induces lower neutralising activity against variants of concern than natural infection - The Lancet Infectious Diseases
  • 08/27 Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar | medRxiv
  • 08/27 Geometric deep learning of RNA structure - Science
  • 08/27 Piercing the fog of the RNA structure-ome - Science
  • 08/27 Importance of epidemiological factors in the evaluation of transmissibility and clinical severity of SARS-CoV-2 variants - The Lancet Infectious Diseases
  • 08/27 Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study - The Lancet Infectious Diseases
  • 08/27 COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses - The Lancet Rheumatology
  • 08/28 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study - The Lancet
  • 08/29 COVID-19-associated hospitalizations among vaccinated and unvaccinated adults ≥18 years – COVID-NET, 13 states, January 1 – July 24, 2021 | medRxiv
  • 08/29 Effect of Salt Substitution on Cardiovascular Events and Death | NEJM
  • 08/30 Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273 | Vaccination | JAMA | JAMA Network
  • 08/30 Durability of Spike Immunoglobin G Antibodies to SARS-CoV-2 Among Health Care Workers With Prior Infection | Infectious Diseases | JAMA Network Open | JAMA Network
  • 08/30 Intramuscular SARS-CoV-2 vaccines elicit varying degrees of plasma and salivary antibody responses as compared to natural infection | medRxiv
  • 08/30 Durability of antibody response to vaccination and surrogate neutralization of emerging variants based on SARS-CoV-2 exposure history | Scientific Reports
  • 08/31 Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk | Allergy and Clinical Immunology | JAMA Network Open | JAMA Network
  • 08/31 Epistasis at the SARS-CoV-2 RBD Interface and the Propitiously Boring Implications for Vaccine Escape | bioRxiv
  • 08/31 Hybrid immunity versus vaccine-induced immunity against SARS CoV2 in Patients with Autoimmune Rheumatic Diseases | medRxiv
  • 08/31 Short Term Reduction in the Odds of Testing Positive for SARS-CoV-2; a Comparison Between Two Doses and Three doses of the BNT162b2 Vaccine | medRxiv
  • 08/31 Intensity and frequency of extreme novel epidemics | PNAS
  • 08/31 Systemic COVID-19 vaccination also enhances the humoral immune response after SARS CoV-2 infection. An approach to criteria for COVID-19 re-immunization is needed. Do we need a third dose? | Research Square
  • 08/31 Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination - Science

    September 2021

  • 09/01 Kidney Outcomes in Long COVID | American Society of Nephrology
  • 09/01 Viral loads of Delta-variant SARS-CoV2 breakthrough infections following vaccination and booster with the BNT162b2 vaccine | medRxiv
  • 09/01 Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce | NEJM
  • 09/01 Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) - The Lancet
  • 09/01 Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine - The Lancet
  • 09/01 Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study - The Lancet Infectious Diseases
  • 09/01 Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial - The Lancet Respiratory Medicine
  • 09/01 Baricitinib: the first immunomodulatory treatment to reduce COVID-19 mortality in a placebo-controlled trial - The Lancet Respiratory Medicine
  • 09/02 Comparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine | Infectious Diseases | JAMA Network Open | JAMA Network
  • 09/02 Use of artificial intelligence for image analysis in breast cancer screening programmes: systematic review of test accuracy | The BMJ
  • 09/02 Longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections reveal limited infectious virus shedding and restricted tissue distribution | medRxiv
  • 09/02 Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2 - Science
  • 09/03 Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination - Science
  • 09/03 Hospitalisation associated with SARS-CoV-2 delta variant in Denmark - The Lancet Infectious Diseases
  • 09/14 Short-range exposure to airborne virus transmission and current guidelines | PNAS
    | Main | News | Articles | Papers| About |